| 003.1 | SALMONELLA SEPTICEMIA |
| 006.0 | ACUTE AMEBIC DYSENTERY WITHOUT ABSCESS |
| 006.1 | CHRONIC INTESTINAL AMEBIASIS WITHOUT ABSCESS |
| 006.2 | AMEBIC NONDYSENTERIC COLITIS |
| 006.3 | AMEBIC LIVER ABSCESS |
| 006.4 | AMEBIC LUNG ABSCESS |
| 006.5 | AMEBIC BRAIN ABSCESS |
| 006.6 | AMEBIC SKIN ULCERATION |
| 006.8 | AMEBIC INFECTION OF OTHER SITES |
| 006.9 | AMEBIASIS UNSPECIFIED |
| 014.00 | TUBERCULOUS PERITONITIS UNSPECIFIED EXAMINATION |
| 014.01 | TUBERCULOUS PERITONITIS BACTERIOLOGICAL OR HISTOLOGICAL
EXAMINATION NOT DONE |
| 014.02 | TUBERCULOUS PERITONITIS BACTERIOLOGICAL OR HISTOLOGICAL
EXAMINATION RESULTS UNKNOWN (AT PRESENT) |
| 014.03 | TUBERCULOUS PERITONITIS TUBERCLE BACILLI FOUND (IN SPUTUM)
BY MICROSCOPY |
| 014.04 | TUBERCULOUS PERITONITIS TUBERCLE BACILLI NOT FOUND (IN
SPUTUM) BY MICROSCOPY BUT FOUND BY BACTERIAL CULTURE |
| 014.05 | TUBERCULOUS PERITONITIS TUBERCLE BACILLI NOT FOUND BY
BACTERIOLOGICAL EXAMINATION BUT TUBERCULOSIS CONFIRMED
HISTOLOGICALLY |
| 014.06 | TUBERCULOUS PERITONITIS TUBERCLE BACILLI NOT FOUND BY
BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION BUT
TUBERCULOSIS CONFIRMED BY OTHER METHODS (INOCULATION OF
ANIMALS) |
| 014.80 | OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS
UNSPECIFIED EXAMINATION |
| 014.81 | OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS
BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION NOT DONE |
| 014.82 | OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS
BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION RESULTS UNKNOWN
(AT PRESENT) |
| 014.83 | OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS
TUBERCLE BACILLI FOUND (IN SPUTUM) BY MICROSCOPY |
| 014.84 | OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS
TUBERCLE BACILLI NOT FOUND (IN SPUTUM) BY MICROSCOPY BUT
FOUND BY BACTERIAL CULTURE |
| 014.85 | OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS
TUBERCLE BACILLI NOT FOUND BY BACTERIOLOGICAL EXAMINATION
BUT TUBERCULOSIS CONFIRMED HISTOLOGICALLY |
| 014.86 | OTHER TUBERCULOSIS OF INTESTINES AND MESENTERIC GLANDS
TUBERCLE BACILLI NOT FOUND BY BACTERIOLOGICAL OR
HISTOLOGICAL EXAMINATION BUT TUBERCULOSIS CONFIRMED BY
OTHER METHODS (INOCULATION OF ANIMALS) |
| 017.90 | TUBERCULOSIS OF OTHER SPECIFIED ORGANS UNSPECIFIED
EXAMINATION |
| 017.91 | TUBERCULOSIS OF OTHER SPECIFIED ORGANS BACTERIOLOGICAL OR
HISTOLOGICAL EXAMINATION NOT DONE |
| 017.92 | TUBERCULOSIS OF OTHER SPECIFIED ORGANS BACTERIOLOGICAL OR
HISTOLOGICAL EXAMINATION RESULTS UNKNOWN (AT PRESENT) |
| 017.93 | TUBERCULOSIS OF OTHER SPECIFIED ORGANS TUBERCLE BACILLI
FOUND (IN SPUTUM) BY MICROSCOPY |
| 017.94 | TUBERCULOSIS OF OTHER SPECIFIED ORGANS TUBERCLE BACILLI NOT
FOUND (IN SPUTUM) BY MICROSCOPY BUT FOUND BY BACTERIAL
CULTURE |
| 017.95 | TUBERCULOSIS OF OTHER SPECIFIED ORGANS TUBERCLE BACILLI NOT
FOUND BY BACTERIOLOGICAL EXAMINATION BUT TUBERCULOSIS
CONFIRMED HISTOLOGICALLY |
| 017.96 | TUBERCULOSIS OF OTHER SPECIFIED ORGANS TUBERCLE BACILLI NOT
FOUND BY BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION BUT
TUBERCULOSIS CONFIRMED BY OTHER METHODS (INOCULATION OF
ANIMALS) |
| 018.90 | UNSPECIFIED MILIARY TUBERCULOSIS UNSPECIFIED EXAMINATION |
| 018.91 | UNSPECIFIED MILIARY TUBERCULOSIS BACTERIOLOGICAL OR
HISTOLOGICAL EXAMINATION NOT DONE |
| 018.92 | UNSPECIFIED MILIARY TUBERCULOSIS BACTERIOLOGICAL OR
HISTOLOGICAL EXAMINATION RESULTS UNKNOWN (AT PRESENT) |
| 018.93 | UNSPECIFIED MILIARY TUBERCULOSIS TUBERCLE BACILLI FOUND (IN
SPUTUM) BY MICROSCOPY |
| 018.94 | UNSPECIFIED MILIARY TUBERCULOSIS TUBERCLE BACILLI NOT FOUND
(IN SPUTUM) BY MICROSCOPY BUT FOUND BY BACTERIAL CULTURE |
| 018.95 | UNSPECIFIED MILIARY TUBERCULOSIS TUBERCLE BACILLI NOT FOUND
BY BACTERIOLOGICAL EXAMINATION BUT TUBERCULOSIS CONFIRMED
HISTOLOGICALLY |
| 018.96 | UNSPECIFIED MILIARY TUBERCULOSIS TUBERCLE BACILLI NOT FOUND
BY BACTERIOLOGICAL OR HISTOLOGICAL EXAMINATION BUT
TUBERCULOSIS CONFIRMED BY OTHER METHODS (INOCULATION OF
ANIMALS) |
| 020.0 | BUBONIC PLAGUE |
| 020.1 | CELLULOCUTANEOUS PLAGUE |
| 020.2 | SEPTICEMIC PLAGUE |
| 020.3 | PRIMARY PNEUMONIC PLAGUE |
| 020.4 | SECONDARY PNEUMONIC PLAGUE |
| 020.5 | PNEUMONIC PLAGUE UNSPECIFIED |
| 020.8 | OTHER SPECIFIED TYPES OF PLAGUE |
| 020.9 | PLAGUE UNSPECIFIED |
| 022.3 | ANTHRAX SEPTICEMIA |
| 027.0 | LISTERIOSIS |
| 027.1 | ERYSIPELOTHRIX INFECTION |
| 030.1 | TUBERCULOID LEPROSY (TYPE T) |
| 032.83 | DIPHTHERITIC PERITONITIS |
| 036.1 | MENINGOCOCCAL ENCEPHALITIS |
| 036.2 | MENINGOCOCCEMIA |
| 038.0 | STREPTOCOCCAL SEPTICEMIA |
| 038.10 | STAPHYLOCOCCAL SEPTICEMIA UNSPECIFIED |
| 038.11 | METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS SEPTICEMIA |
| 038.12 | METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS SEPTICEMIA |
| 038.19 | OTHER STAPHYLOCOCCAL SEPTICEMIA |
| 038.2 | PNEUMOCOCCAL SEPTICEMIA |
| 038.3 | SEPTICEMIA DUE TO ANAEROBES |
| 038.40 | SEPTICEMIA DUE TO GRAM-NEGATIVE ORGANISM UNSPECIFIED |
| 038.41 | SEPTICEMIA DUE TO HEMOPHILUS INFLUENZAE (H. INFLUENZAE) |
| 038.42 | SEPTICEMIA DUE TO ESCHERICHIA COLI (E. COLI) |
| 038.43 | SEPTICEMIA DUE TO PSEUDOMONAS |
| 038.44 | SEPTICEMIA DUE TO SERRATIA |
| 038.49 | OTHER SEPTICEMIA DUE TO GRAM-NEGATIVE ORGANISMS |
| 038.8 | OTHER SPECIFIED SEPTICEMIAS |
| 038.9 | UNSPECIFIED SEPTICEMIA |
| 038.12 | METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS SEPTICEMIA |
| 039.2 | ABDOMINAL ACTINOMYCOTIC INFECTION |
| 040.0 | GAS GANGRENE |
| 042 | HUMAN IMMUNODEFICIENCY VIRUS (HIV) DISEASE |
| 054.0 | ECZEMA HERPETICUM |
| 054.5 | HERPETIC SEPTICEMIA |
| 060.0 | SYLVATIC YELLOW FEVER |
| 060.1 | URBAN YELLOW FEVER |
| 070.0 | VIRAL HEPATITIS A WITH HEPATIC COMA |
| 070.1 | VIRAL HEPATITIS A WITHOUT HEPATIC COMA |
| 070.20 | VIRAL HEPATITIS B WITH HEPATIC COMA ACUTE OR UNSPECIFIED
WITHOUT HEPATITIS DELTA |
| 070.21 | VIRAL HEPATITIS B WITH HEPATIC COMA ACUTE OR UNSPECIFIED
WITH HEPATITIS DELTA |
| 070.22 | CHRONIC VIRAL HEPATITIS B WITH HEPATIC COMA WITHOUT
HEPATITIS DELTA |
| 070.23 | CHRONIC VIRAL HEPATITIS B WITH HEPATIC COMA WITH HEPATITIS
DELTA |
| 070.30 | VIRAL HEPATITIS B WITHOUT HEPATIC COMA ACUTE OR UNSPECIFIED
WITHOUT HEPATITIS DELTA |
| 070.31 | VIRAL HEPATITIS B WITHOUT HEPATIC COMA ACUTE OR UNSPECIFIED
WITH HEPATITIS DELTA |
| 070.32 | CHRONIC VIRAL HEPATITIS B WITHOUT HEPATIC COMA WITHOUT
HEPATITIS DELTA |
| 070.33 | CHRONIC VIRAL HEPATITIS B WITHOUT HEPATIC COMA WITH
HEPATITIS DELTA |
| 070.41 | ACUTE HEPATITIS C WITH HEPATIC COMA |
| 070.42 | HEPATITIS DELTA WITHOUT ACTIVE HEPATITIS B DISEASE WITH
HEPATIC COMA HEPATITIS DELTA WITH HEPATITIS B CARRIER STATE |
| 070.43 | HEPATITIS E WITH HEPATIC COMA |
| 070.44 | CHRONIC HEPATITIS C WITH HEPATIC COMA |
| 070.49 | OTHER SPECIFIED VIRAL HEPATITIS WITH HEPATIC COMA |
| 070.51 | ACUTE HEPATITIS C WITHOUT MENTION OF HEPATIC COMA |
| 070.52 | HEPATITIS DELTA WITHOUT ACTIVE HEPATITIS B DISEASE OR
HEPATIC COMA |
| 070.53 | HEPATITIS E WITHOUT HEPATIC COMA |
| 070.54 | CHRONIC HEPATITIS C WITHOUT HEPATIC COMA |
| 070.59 | OTHER SPECIFIED VIRAL HEPATITIS WITHOUT HEPATIC COMA |
| 070.6 | UNSPECIFIED VIRAL HEPATITIS WITH HEPATIC COMA |
| 070.70 | UNSPECIFIED VIRAL HEPATITIS C WITHOUT HEPATIC COMA |
| 070.71 | UNSPECIFIED VIRAL HEPATITIS C WITH HEPATIC COMA |
| 070.9 | UNSPECIFIED VIRAL HEPATITIS WITHOUT HEPATIC COMA |
| 072.71 | MUMPS HEPATITIS |
| 073.0 | ORNITHOSIS WITH PNEUMONIA |
| 074.8 | OTHER SPECIFIED DISEASES DUE TO COXSACKIE VIRUS |
| 075 | INFECTIOUS MONONUCLEOSIS |
| 078.5 | CYTOMEGALOVIRAL DISEASE |
| 079.99 | UNSPECIFIED VIRAL INFECTION |
| 082.0 | SPOTTED FEVERS |
| 082.1 | BOUTONNEUSE FEVER |
| 082.2 | NORTH ASIAN TICK FEVER |
| 082.3 | QUEENSLAND TICK TYPHUS |
| 082.40 | UNSPECIFIED EHRLICHIOSIS |
| 082.41 | EHRLICHIOSIS CHAFEENSIS (E CHAFEENSIS) |
| 082.49 | OTHER EHRLICHIOSIS |
| 082.8 | OTHER SPECIFIED TICK-BORNE RICKETTSIOSES |
| 082.9 | TICK-BORNE RICKETTSIOSIS UNSPECIFIED |
| 084.9 | OTHER PERNICIOUS COMPLICATIONS OF MALARIA |
| 086.1 | CHAGAS' DISEASE WITH OTHER ORGAN INVOLVEMENT |
| 088.81 | LYME DISEASE |
| 091.62 | SECONDARY SYPHILITIC HEPATITIS |
| 095.3 | SYPHILIS OF LIVER |
| 100.0 | LEPTOSPIROSIS ICTEROHEMORRHAGICA |
| 112.5 | DISSEMINATED CANDIDIASIS |
| 115.00 | INFECTION BY HISTOPLASMA CAPSULATUM WITHOUT MANIFESTATION |
| 120.9 | SCHISTOSOMIASIS UNSPECIFIED |
| 121.1 | CLONORCHIASIS |
| 121.3 | FASCIOLIASIS |
| 122.0 | ECHINOCOCCUS GRANULOSUS INFECTION OF LIVER |
| 122.5 | ECHINOCOCCUS MULTILOCULARIS INFECTION OF LIVER |
| 122.8 | ECHINOCOCCOSIS UNSPECIFIED OF LIVER |
| 122.9 | ECHINOCOCCOSIS OTHER AND UNSPECIFIED |
| 130.5 | HEPATITIS DUE TO TOXOPLASMOSIS |
| 135 | SARCOIDOSIS |
| 150.0 | MALIGNANT NEOPLASM OF CERVICAL ESOPHAGUS |
| 150.1 | MALIGNANT NEOPLASM OF THORACIC ESOPHAGUS |
| 150.2 | MALIGNANT NEOPLASM OF ABDOMINAL ESOPHAGUS |
| 150.3 | MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS |
| 150.4 | MALIGNANT NEOPLASM OF MIDDLE THIRD OF ESOPHAGUS |
| 150.5 | MALIGNANT NEOPLASM OF LOWER THIRD OF ESOPHAGUS |
| 150.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED PART OF ESOPHAGUS |
| 150.9 | MALIGNANT NEOPLASM OF ESOPHAGUS UNSPECIFIED SITE |
| 151.0 | MALIGNANT NEOPLASM OF CARDIA |
| 151.1 | MALIGNANT NEOPLASM OF PYLORUS |
| 151.2 | MALIGNANT NEOPLASM OF PYLORIC ANTRUM |
| 151.3 | MALIGNANT NEOPLASM OF FUNDUS OF STOMACH |
| 151.4 | MALIGNANT NEOPLASM OF BODY OF STOMACH |
| 151.5 | MALIGNANT NEOPLASM OF LESSER CURVATURE OF STOMACH
UNSPECIFIED |
| 151.6 | MALIGNANT NEOPLASM OF GREATER CURVATURE OF STOMACH
UNSPECIFIED |
| 151.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF STOMACH |
| 151.9 | MALIGNANT NEOPLASM OF STOMACH UNSPECIFIED SITE |
| 152.0 | MALIGNANT NEOPLASM OF DUODENUM |
| 152.1 | MALIGNANT NEOPLASM OF JEJUNUM |
| 152.2 | MALIGNANT NEOPLASM OF ILEUM |
| 152.3 | MALIGNANT NEOPLASM OF MECKEL'S DIVERTICULUM |
| 152.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF SMALL
INTESTINE |
| 152.9 | MALIGNANT NEOPLASM OF SMALL INTESTINE UNSPECIFIED SITE |
| 153.0 | MALIGNANT NEOPLASM OF HEPATIC FLEXURE |
| 153.1 | MALIGNANT NEOPLASM OF TRANSVERSE COLON |
| 153.2 | MALIGNANT NEOPLASM OF DESCENDING COLON |
| 153.3 | MALIGNANT NEOPLASM OF SIGMOID COLON |
| 153.4 | MALIGNANT NEOPLASM OF CECUM |
| 153.5 | MALIGNANT NEOPLASM OF APPENDIX VERMIFORMIS |
| 153.6 | MALIGNANT NEOPLASM OF ASCENDING COLON |
| 153.7 | MALIGNANT NEOPLASM OF SPLENIC FLEXURE |
| 153.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF LARGE
INTESTINE |
| 153.9 | MALIGNANT NEOPLASM OF COLON UNSPECIFIED SITE |
| 154.0 | MALIGNANT NEOPLASM OF RECTOSIGMOID JUNCTION |
| 154.1 | MALIGNANT NEOPLASM OF RECTUM |
| 154.2 | MALIGNANT NEOPLASM OF ANAL CANAL |
| 154.3 | MALIGNANT NEOPLASM OF ANUS UNSPECIFIED SITE |
| 154.8 | MALIGNANT NEOPLASM OF OTHER SITES OF RECTUM RECTOSIGMOID
JUNCTION AND ANUS |
| 155.0 | MALIGNANT NEOPLASM OF LIVER PRIMARY |
| 155.1 | MALIGNANT NEOPLASM OF INTRAHEPATIC BILE DUCTS |
| 155.2 | MALIGNANT NEOPLASM OF LIVER NOT SPECIFIED AS PRIMARY OR
SECONDARY |
| 156.0 | MALIGNANT NEOPLASM OF GALLBLADDER |
| 156.1 | MALIGNANT NEOPLASM OF EXTRAHEPATIC BILE DUCTS |
| 156.2 | MALIGNANT NEOPLASM OF AMPULLA OF VATER |
| 156.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF GALLBLADDER
AND EXTRAHEPATIC BILE DUCTS |
| 156.9 | MALIGNANT NEOPLASM OF BILIARY TRACT PART UNSPECIFIED SITE |
| 157.0 | MALIGNANT NEOPLASM OF HEAD OF PANCREAS |
| 157.1 | MALIGNANT NEOPLASM OF BODY OF PANCREAS |
| 157.2 | MALIGNANT NEOPLASM OF TAIL OF PANCREAS |
| 157.3 | MALIGNANT NEOPLASM OF PANCREATIC DUCT |
| 157.4 | MALIGNANT NEOPLASM OF ISLETS OF LANGERHANS |
| 157.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF PANCREAS |
| 157.9 | MALIGNANT NEOPLASM OF PANCREAS PART UNSPECIFIED |
| 158.0 | MALIGNANT NEOPLASM OF RETROPERITONEUM |
| 158.8 | MALIGNANT NEOPLASM OF SPECIFIED PARTS OF PERITONEUM |
| 158.9 | MALIGNANT NEOPLASM OF PERITONEUM UNSPECIFIED |
| 159.0 | MALIGNANT NEOPLASM OF INTESTINAL TRACT PART UNSPECIFIED |
| 159.1 | MALIGNANT NEOPLASM OF SPLEEN NOT ELSEWHERE CLASSIFIED |
| 159.8 | MALIGNANT NEOPLASM OF OTHER SITES OF DIGESTIVE SYSTEM AND
INTRA-ABDOMINAL ORGANS |
| 159.9 | MALIGNANT NEOPLASM OF ILL-DEFINED SITES WITHIN THE
DIGESTIVE ORGANS AND PERITONEUM |
| 160.0 | MALIGNANT NEOPLASM OF NASAL CAVITIES |
| 160.1 | MALIGNANT NEOPLASM OF AUDITORY TUBE MIDDLE EAR AND MASTOID
AIR CELLS |
| 160.2 | MALIGNANT NEOPLASM OF MAXILLARY SINUS |
| 160.3 | MALIGNANT NEOPLASM OF ETHMOIDAL SINUS |
| 160.4 | MALIGNANT NEOPLASM OF FRONTAL SINUS |
| 160.5 | MALIGNANT NEOPLASM OF SPHENOIDAL SINUS |
| 160.8 | MALIGNANT NEOPLASM OF OTHER ACCESSORY SINUSES |
| 160.9 | MALIGNANT NEOPLASM OF ACCESSORY SINUS UNSPECIFIED |
| 161.0 | MALIGNANT NEOPLASM OF GLOTTIS |
| 161.1 | MALIGNANT NEOPLASM OF SUPRAGLOTTIS |
| 161.2 | MALIGNANT NEOPLASM OF SUBGLOTTIS |
| 161.3 | MALIGNANT NEOPLASM OF LARYNGEAL CARTILAGES |
| 161.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF LARYNX |
| 161.9 | MALIGNANT NEOPLASM OF LARYNX UNSPECIFIED |
| 162.0 | MALIGNANT NEOPLASM OF TRACHEA |
| 162.2 | MALIGNANT NEOPLASM OF MAIN BRONCHUS |
| 162.3 | MALIGNANT NEOPLASM OF UPPER LOBE BRONCHUS OR LUNG |
| 162.4 | MALIGNANT NEOPLASM OF MIDDLE LOBE BRONCHUS OR LUNG |
| 162.5 | MALIGNANT NEOPLASM OF LOWER LOBE BRONCHUS OR LUNG |
| 162.8 | MALIGNANT NEOPLASM OF OTHER PARTS OF BRONCHUS OR LUNG |
| 162.9 | MALIGNANT NEOPLASM OF BRONCHUS AND LUNG UNSPECIFIED |
| 163.0 | MALIGNANT NEOPLASM OF PARIETAL PLEURA |
| 163.1 | MALIGNANT NEOPLASM OF VISCERAL PLEURA |
| 163.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF PLEURA |
| 163.9 | MALIGNANT NEOPLASM OF PLEURA UNSPECIFIED |
| 164.0 | MALIGNANT NEOPLASM OF THYMUS |
| 164.1 | MALIGNANT NEOPLASM OF HEART |
| 164.2 | MALIGNANT NEOPLASM OF ANTERIOR MEDIASTINUM |
| 164.3 | MALIGNANT NEOPLASM OF POSTERIOR MEDIASTINUM |
| 164.8 | MALIGNANT NEOPLASM OF OTHER PARTS OF MEDIASTINUM |
| 164.9 | MALIGNANT NEOPLASM OF MEDIASTINUM PART UNSPECIFIED |
| 165.0 | MALIGNANT NEOPLASM OF UPPER RESPIRATORY TRACT PART
UNSPECIFIED |
| 165.8 | MALIGNANT NEOPLASM OF OTHER SITES WITHIN THE RESPIRATORY
SYSTEM AND INTRATHORACIC ORGANS |
| 165.9 | MALIGNANT NEOPLASM OF ILL-DEFINED SITES WITHIN THE
RESPIRATORY SYSTEM |
| 170.0 | MALIGNANT NEOPLASM OF BONES OF SKULL AND FACE EXCEPT
MANDIBLE |
| 170.1 | MALIGNANT NEOPLASM OF MANDIBLE |
| 170.2 | MALIGNANT NEOPLASM OF VERTEBRAL COLUMN EXCLUDING SACRUM AND
COCCYX |
| 170.3 | MALIGNANT NEOPLASM OF RIBS STERNUM AND CLAVICLE |
| 170.4 | MALIGNANT NEOPLASM OF SCAPULA AND LONG BONES OF UPPER LIMB |
| 170.5 | MALIGNANT NEOPLASM OF SHORT BONES OF UPPER LIMB |
| 170.6 | MALIGNANT NEOPLASM OF PELVIC BONES SACRUM AND COCCYX |
| 170.7 | MALIGNANT NEOPLASM OF LONG BONES OF LOWER LIMB |
| 170.8 | MALIGNANT NEOPLASM OF SHORT BONES OF LOWER LIMB |
| 170.9 | MALIGNANT NEOPLASM OF BONE AND ARTICULAR CARTILAGE SITE
UNSPECIFIED |
| 171.0 | MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF
HEAD FACE AND NECK |
| 171.2 | MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF
UPPER LIMB INCLUDING SHOULDER |
| 171.3 | MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF
LOWER LIMB INCLUDING HIP |
| 171.4 | MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF
THORAX |
| 171.5 | MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF
ABDOMEN |
| 171.6 | MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF
PELVIS |
| 171.7 | MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF
TRUNK UNSPECIFIED |
| 171.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF CONNECTIVE
AND OTHER SOFT TISSUE |
| 171.9 | MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE SITE
UNSPECIFIED |
| 172.0 | MALIGNANT MELANOMA OF SKIN OF LIP |
| 172.1 | MALIGNANT MELANOMA OF SKIN OF EYELID INCLUDING CANTHUS |
| 172.2 | MALIGNANT MELANOMA OF SKIN OF EAR AND EXTERNAL AUDITORY
CANAL |
| 172.3 | MALIGNANT MELANOMA OF SKIN OF OTHER AND UNSPECIFIED PARTS
OF FACE |
| 172.4 | MALIGNANT MELANOMA OF SKIN OF SCALP AND NECK |
| 172.5 | MALIGNANT MELANOMA OF SKIN OF TRUNK EXCEPT SCROTUM |
| 172.6 | MALIGNANT MELANOMA OF SKIN OF UPPER LIMB INCLUDING SHOULDER |
| 172.7 | MALIGNANT MELANOMA OF SKIN OF LOWER LIMB INCLUDING HIP |
| 172.8 | MALIGNANT MELANOMA OF OTHER SPECIFIED SITES OF SKIN |
| 172.9 | MELANOMA OF SKIN SITE UNSPECIFIED |
| 173.0 | OTHER MALIGNANT NEOPLASM OF SKIN OF LIP |
| 173.1 | OTHER MALIGNANT NEOPLASM OF SKIN OF EYELID INCLUDING
CANTHUS |
| 173.2 | OTHER MALIGNANT NEOPLASM OF SKIN OF EAR AND EXTERNAL
AUDITORY CANAL |
| 173.3 | OTHER MALIGNANT NEOPLASM OF SKIN OF OTHER AND UNSPECIFIED
PARTS OF FACE |
| 173.4 | OTHER MALIGNANT NEOPLASM OF SCALP AND SKIN OF NECK |
| 173.5 | OTHER MALIGNANT NEOPLASM OF SKIN OF TRUNK EXCEPT SCROTUM |
| 173.6 | OTHER MALIGNANT NEOPLASM OF SKIN OF UPPER LIMB INCLUDING
SHOULDER |
| 173.7 | OTHER MALIGNANT NEOPLASM OF SKIN OF LOWER LIMB INCLUDING
HIP |
| 173.8 | OTHER MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF SKIN |
| 173.9 | OTHER MALIGNANT NEOPLASM OF SKIN SITE UNSPECIFIED |
| 174.0 | MALIGNANT NEOPLASM OF NIPPLE AND AREOLA OF FEMALE BREAST |
| 174.1 | MALIGNANT NEOPLASM OF CENTRAL PORTION OF FEMALE BREAST |
| 174.2 | MALIGNANT NEOPLASM OF UPPER-INNER QUADRANT OF FEMALE BREAST |
| 174.3 | MALIGNANT NEOPLASM OF LOWER-INNER QUADRANT OF FEMALE BREAST |
| 174.4 | MALIGNANT NEOPLASM OF UPPER-OUTER QUADRANT OF FEMALE BREAST |
| 174.5 | MALIGNANT NEOPLASM OF LOWER-OUTER QUADRANT OF FEMALE BREAST |
| 174.6 | MALIGNANT NEOPLASM OF AXILLARY TAIL OF FEMALE BREAST |
| 174.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF FEMALE
BREAST |
| 174.9 | MALIGNANT NEOPLASM OF BREAST (FEMALE) UNSPECIFIED SITE |
| 175.0 | MALIGNANT NEOPLASM OF NIPPLE AND AREOLA OF MALE BREAST |
| 175.9 | MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED SITES OF MALE
BREAST |
| 176.0 | KAPOSI'S SARCOMA SKIN |
| 176.1 | KAPOSI'S SARCOMA SOFT TISSUE |
| 176.2 | KAPOSI'S SARCOMA PALATE |
| 176.3 | KAPOSI'S SARCOMA GASTROINTESTINAL SITES |
| 176.4 | KAPOSI'S SARCOMA LUNG |
| 176.5 | KAPOSI'S SARCOMA LYMPH NODES |
| 176.8 | KAPOSI'S SARCOMA OTHER SPECIFIED SITES |
| 176.9 | KAPOSI'S SARCOMA UNSPECIFIED SITE |
| 179 | MALIGNANT NEOPLASM OF UTERUS-PART UNS |
| 180.0 | MALIGNANT NEOPLASM OF ENDOCERVIX |
| 180.1 | MALIGNANT NEOPLASM OF EXOCERVIX |
| 180.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF CERVIX |
| 180.9 | MALIGNANT NEOPLASM OF CERVIX UTERI UNSPECIFIED SITE |
| 181 | MALIGNANT NEOPLASM OF PLACENTA |
| 182.0 | MALIGNANT NEOPLASM OF CORPUS UTERI EXCEPT ISTHMUS |
| 182.1 | MALIGNANT NEOPLASM OF ISTHMUS |
| 182.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF BODY OF
UTERUS |
| 183.0 | MALIGNANT NEOPLASM OF OVARY |
| 183.2 | MALIGNANT NEOPLASM OF FALLOPIAN TUBE |
| 183.3 | MALIGNANT NEOPLASM OF BROAD LIGAMENT OF UTERUS |
| 183.4 | MALIGNANT NEOPLASM OF PARAMETRIUM |
| 183.5 | MALIGNANT NEOPLASM OF ROUND LIGAMENT OF UTERUS |
| 183.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF UTERINE
ADNEXA |
| 183.9 | MALIGNANT NEOPLASM OF UTERINE ADNEXA UNSPECIFIED SITE |
| 184.0 | MALIGNANT NEOPLASM OF VAGINA |
| 184.1 | MALIGNANT NEOPLASM OF LABIA MAJORA |
| 184.2 | MALIGNANT NEOPLASM OF LABIA MINORA |
| 184.3 | MALIGNANT NEOPLASM OF CLITORIS |
| 184.4 | MALIGNANT NEOPLASM OF VULVA UNSPECIFIED SITE |
| 184.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF FEMALE
GENITAL ORGANS |
| 184.9 | MALIGNANT NEOPLASM OF FEMALE GENITAL ORGAN SITE UNSPECIFIED |
| 185 | MALIGNANT NEOPLASM OF PROSTATE |
| 186.0 | MALIGNANT NEOPLASM OF UNDESCENDED TESTIS |
| 186.9 | MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED TESTIS |
| 187.1 | MALIGNANT NEOPLASM OF PREPUCE |
| 187.2 | MALIGNANT NEOPLASM OF GLANS PENIS |
| 187.3 | MALIGNANT NEOPLASM OF BODY OF PENIS |
| 187.4 | MALIGNANT NEOPLASM OF PENIS PART UNSPECIFIED |
| 187.5 | MALIGNANT NEOPLASM OF EPIDIDYMIS |
| 187.6 | MALIGNANT NEOPLASM OF SPERMATIC CORD |
| 187.7 | MALIGNANT NEOPLASM OF SCROTUM |
| 187.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF MALE GENITAL
ORGANS |
| 187.9 | MALIGNANT NEOPLASM OF MALE GENITAL ORGAN SITE UNSPECIFIED |
| 188.0 | MALIGNANT NEOPLASM OF TRIGONE OF URINARY BLADDER |
| 188.1 | MALIGNANT NEOPLASM OF DOME OF URINARY BLADDER |
| 188.2 | MALIGNANT NEOPLASM OF LATERAL WALL OF URINARY BLADDER |
| 188.3 | MALIGNANT NEOPLASM OF ANTERIOR WALL OF URINARY BLADDER |
| 188.4 | MALIGNANT NEOPLASM OF POSTERIOR WALL OF URINARY BLADDER |
| 188.5 | MALIGNANT NEOPLASM OF BLADDER NECK |
| 188.6 | MALIGNANT NEOPLASM OF URETERIC ORIFICE |
| 188.7 | MALIGNANT NEOPLASM OF URACHUS |
| 188.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF BLADDER |
| 188.9 | MALIGNANT NEOPLASM OF BLADDER PART UNSPECIFIED |
| 189.0 | MALIGNANT NEOPLASM OF KIDNEY EXCEPT PELVIS |
| 189.1 | MALIGNANT NEOPLASM OF RENAL PELVIS |
| 189.2 | MALIGNANT NEOPLASM OF URETER |
| 189.3 | MALIGNANT NEOPLASM OF URETHRA |
| 189.4 | MALIGNANT NEOPLASM OF PARAURETHRAL GLANDS |
| 189.8 | MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF URINARY
ORGANS |
| 189.9 | MALIGNANT NEOPLASM OF URINARY ORGAN SITE UNSPECIFIED |
| 200.00 | RETICULOSARCOMA UNSPECIFIED SITE |
| 200.01 | RETICULOSARCOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK |
| 200.02 | RETICULOSARCOMA INVOLVING INTRATHORACIC LYMPH NODES |
| 200.03 | RETICULOSARCOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES |
| 200.04 | RETICULOSARCOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER
LIMB |
| 200.05 | RETICULOSARCOMA INVOLVING LYMPH NODES OF INGUINAL REGION
AND LOWER LIMB |
| 200.06 | RETICULOSARCOMA INVOLVING INTRAPELVIC LYMPH NODES |
| 200.07 | RETICULOSARCOMA INVOLVING SPLEEN |
| 200.08 | RETICULOSARCOMA INVOLVING LYMPH NODES OF MULTIPLE SITES |
| 200.10 | LYMPHOSARCOMA UNSPECIFIED SITE |
| 200.11 | LYMPHOSARCOMA INVOLVING LYMPH NODES OF HEAD FACE AND NECK |
| 200.12 | LYMPHOSARCOMA INVOLVING INTRATHORACIC LYMPH NODES |
| 200.13 | LYMPHOSARCOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES |
| 200.14 | LYMPHOSARCOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER
LIMB |
| 200.15 | LYMPHOSARCOMA INVOLVING LYMPH NODES OF INGUINAL REGION AND
LOWER LIMB |
| 200.16 | LYMPHOSARCOMA INVOLVING INTRAPELVIC LYMPH NODES |
| 200.17 | LYMPHOSARCOMA INVOLVING SPLEEN |
| 200.18 | LYMPHOSARCOMA INVOLVING LYMPH NODES OF MULTIPLE SITES |
| 200.20 | BURKITT'S TUMOR OR LYMPHOMA UNSPECIFIED SITE |
| 200.21 | BURKITT'S TUMOR OR LYMPHOMA INVOLVING LYMPH NODES OF HEAD
FACE AND NECK |
| 200.22 | BURKITT'S TUMOR OR LYMPHOMA INVOLVING INTRATHORACIC LYMPH
NODES |
| 200.23 | BURKITT'S TUMOR OR LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH
NODES |
| 200.24 | BURKITT'S TUMOR OR LYMPHOMA INVOLVING LYMPH NODES OF AXILLA
AND UPPER LIMB |
| 200.25 | BURKITT'S TUMOR OR LYMPHOMA INVOLVING LYMPH NODES OF
INGUINAL REGION AND LOWER LIMB |
| 200.26 | BURKITT'S TUMOR OR LYMPHOMA INVOLVING INTRAPELVIC LYMPH
NODES |
| 200.27 | BURKITT'S TUMOR OR LYMPHOMA INVOLVING SPLEEN |
| 200.28 | BURKITT'S TUMOR OR LYMPHOMA INVOLVING LYMPH NODES OF
MULTIPLE SITES |
| 200.30 | MARGINAL ZONE LYMPHOMA UNSPECIFIED SITE |
| 200.31 | MARGINAL ZONE LYMPHOMA INVOLVING LYMPH NODES OF HEAD FACE
AND NECK |
| 200.32 | MARGINAL ZONE LYMPHOMA INVOLVING INTRATHORACIC LYMPH NODES |
| 200.33 | MARGINAL ZONE LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH
NODES |
| 200.34 | MARGINAL ZONE LYMPHOMA INVOLVING LYMPH NODES OF AXILLA AND
UPPER LIMB |
| 200.35 | MARGINAL ZONE LYMPHOMA INVOLVING LYMPH NODES OF INGUINAL
REGION AND LOWER LIMB |
| 200.36 | MARGINAL ZONE LYMPHOMA INVOLVING INTRAPELVIC LYMPH NODES |
| 200.37 | MARGINAL ZONE LYMPHOMA INVOLVING SPLEEN |
| 200.38 | MARGINAL ZONE LYMPHOMA INVOLVING LYMPH NODES OF MULTIPLE
SITES |
| 200.40 | MANTLE CELL LYMPHOMA UNSPECIFIED SITE |
| 200.41 | MANTLE CELL LYMPHOMA INVOLVING LYMPH NODES OF HEAD FACE AND
NECK |
| 200.42 | MANTLE CELL LYMPHOMA INVOLVING INTRATHORACIC LYMPH NODES |
| 200.43 | MANTLE CELL LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES |
| 200.44 | MANTLE CELL LYMPHOMA INVOLVING LYMPH NODES OF AXILLA AND
UPPER LIMB |
| 200.45 | MANTLE CELL LYMPHOMA INVOLVING LYMPH NODES OF INGUINAL
REGION AND LOWER LIMB |
| 200.46 | MANTLE CELL LYMPHOMA INVOLVING INTRAPELVIC LYMPH NODES |
| 200.47 | MANTLE CELL LYMPHOMA INVOLVING SPLEEN |
| 200.48 | MANTLE CELL LYMPHOMA INVOLVING LYMPH NODES OF MULTIPLE
SITES |
| 200.50 | PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA UNSPECIFIED SITE |
| 200.51 | PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING LYMPH
NODES OF HEAD FACE AND NECK |
| 200.52 | PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING
INTRATHORACIC LYMPH NODES |
| 200.53 | PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING
INTRA-ABDOMINAL LYMPH NODES |
| 200.54 | PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING LYMPH
NODES OF AXILLA AND UPPER LIMB |
| 200.55 | PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING LYMPH
NODES OF INGUINAL REGION AND LOWER LIMB |
| 200.56 | PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING
INTRAPELVIC LYMPH NODES |
| 200.57 | PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING SPLEEN |
| 200.58 | PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA INVOLVING LYMPH
NODES OF MULTIPLE SITES |
| 200.60 | ANAPLASTIC LARGE CELL LYMPHOMA UNSPECIFIED SITE |
| 200.61 | ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF
HEAD FACE AND NECK |
| 200.62 | ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING INTRATHORACIC
LYMPH NODES |
| 200.63 | ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING INTRA-ABDOMINAL
LYMPH NODES |
| 200.64 | ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF
AXILLA AND UPPER LIMB |
| 200.65 | ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF
INGUINAL REGION AND LOWER LIMB |
| 200.66 | ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING INTRAPELVIC LYMPH
NODES |
| 200.67 | ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING SPLEEN |
| 200.68 | ANAPLASTIC LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF
MULTIPLE SITES |
| 200.70 | LARGE CELL LYMPHOMA UNSPECIFIED SITE |
| 200.71 | LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF HEAD FACE AND
NECK |
| 200.72 | LARGE CELL LYMPHOMA INVOLVING INTRATHORACIC LYMPH NODES |
| 200.73 | LARGE CELL LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES |
| 200.74 | LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF AXILLA AND
UPPER LIMB |
| 200.75 | LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF INGUINAL
REGION AND LOWER LIMB |
| 200.76 | LARGE CELL LYMPHOMA INVOLVING INTRAPELVIC LYMPH NODES |
| 200.77 | LARGE CELL LYMPHOMA INVOLVING SPLEEN |
| 200.78 | LARGE CELL LYMPHOMA INVOLVING LYMPH NODES OF MULTIPLE SITES |
| 200.80 | OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA
UNSPECIFIED SITE |
| 200.81 | OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA
INVOLVING LYMPH NODES OF HEAD FACE AND NECK |
| 200.82 | OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA
INVOLVING INTRATHORACIC LYMPH NODES |
| 200.83 | OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA
INVOLVING INTRA-ABDOMINAL LYMPH NODES |
| 200.84 | OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA
INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB |
| 200.85 | OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA
INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB |
| 200.86 | OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA
INVOLVING INTRAPELVIC LYMPH NODES |
| 200.87 | OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA
INVOLVING SPLEEN |
| 200.88 | OTHER NAMED VARIANTS OF LYMPHOSARCOMA AND RETICULOSARCOMA
INVOLVING LYMPH NODES OF MULTIPLE SITES |
| 201.00 | HODGKIN'S PARAGRANULOMA UNSPECIFIED SITE |
| 201.01 | HODGKIN'S PARAGRANULOMA INVOLVING LYMPH NODES OF HEAD FACE
AND NECK |
| 201.02 | HODGKIN'S PARAGRANULOMA INVOLVING INTRATHORACIC LYMPH NODES |
| 201.03 | HODGKIN'S PARAGRANULOMA INVOLVING INTRA-ABDOMINAL LYMPH
NODES |
| 201.04 | HODGKIN'S PARAGRANULOMA INVOLVING LYMPH NODES OF AXILLA AND
UPPER LIMB |
| 201.05 | HODGKIN'S PARAGRANULOMA INVOLVING LYMPH NODES OF INGUINAL
REGION AND LOWER LIMB |
| 201.06 | HODGKIN'S PARAGRANULOMA INVOLVING INTRAPELVIC LYMPH NODES |
| 201.07 | HODGKIN'S PARAGRANULOMA INVOLVING SPLEEN |
| 201.08 | HODGKIN'S PARAGRANULOMA INVOLVING LYMPH NODES OF MULTIPLE
SITES |
| 201.10 | HODGKIN'S GRANULOMA UNSPECIFIED SITE |
| 201.11 | HODGKIN'S GRANULOMA INVOLVING LYMPH NODES OF HEAD FACE AND
NECK |
| 201.12 | HODGKIN'S GRANULOMA INVOLVING INTRATHORACIC LYMPH NODES |
| 201.13 | HODGKIN'S GRANULOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES |
| 201.14 | HODGKIN'S GRANULOMA INVOLVING LYMPH NODES OF AXILLA AND
UPPER LIMB |
| 201.15 | HODGKIN'S GRANULOMA INVOLVING LYMPH NODES OF INGUINAL
REGION AND LOWER LIMB |
| 201.16 | HODGKIN'S GRANULOMA INVOLVING INTRAPELVIC LYMPH NODES |
| 201.17 | HODGKIN'S GRANULOMA INVOLVING SPLEEN |
| 201.18 | HODGKIN'S GRANULOMA INVOLVING LYMPH NODES OF MULTIPLE SITES |
| 201.20 | HODGKIN'S SARCOMA UNSPECIFIED SITE |
| 201.21 | HODGKIN'S SARCOMA INVOLVING LYMPH NODES OF HEAD FACE AND
NECK |
| 201.22 | HODGKIN'S SARCOMA INVOLVING INTRATHORACIC LYMPH NODES |
| 201.23 | HODGKIN'S SARCOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES |
| 201.24 | HODGKIN'S SARCOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER
LIMB |
| 201.25 | HODGKIN'S SARCOMA INVOLVING LYMPH NODES OF INGUINAL REGION
AND LOWER LIMB |
| 201.26 | HODGKIN'S SARCOMA INVOLVING INTRAPELVIC LYMPH NODES |
| 201.27 | HODGKIN'S SARCOMA INVOLVING SPLEEN |
| 201.28 | HODGKIN'S SARCOMA INVOLVING LYMPH NODES OF MULTIPLE SITES |
| 201.40 | HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE
UNSPECIFIED SITE |
| 201.41 | HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE
INVOLVING LYMPH NODES OF HEAD FACE AND NECK |
| 201.42 | HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE
INVOLVING INTRATHORACIC LYMPH NODES |
| 201.43 | HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE
INVOLVING INTRA-ABDOMINAL LYMPH NODES |
| 201.44 | HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE
INVOLVING LYMPH NODES OF AXILLA AND UPPER LIMB |
| 201.45 | HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE
INVOLVING LYMPH NODES OF INGUINAL REGION AND LOWER LIMB |
| 201.46 | HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE
INVOLVING INTRAPELVIC LYMPH NODES |
| 201.47 | HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE
INVOLVING SPLEEN |
| 201.48 | HODGKIN'S DISEASE LYMPHOCYTIC-HISTIOCYTIC PREDOMINANCE
INVOLVING LYMPH NODES OF MULTIPLE SITES |
| 201.50 | HODGKIN'S DISEASE NODULAR SCLEROSIS UNSPECIFIED SITE |
| 201.51 | HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING LYMPH NODES
OF HEAD FACE AND NECK |
| 201.52 | HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING INTRATHORACIC
LYMPH NODES |
| 201.53 | HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING
INTRA-ABDOMINAL LYMPH NODES |
| 201.54 | HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING LYMPH NODES
OF AXILLA AND UPPER LIMB |
| 201.55 | HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING LYMPH NODES
OF INGUINAL REGION AND LOWER LIMB |
| 201.56 | HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING INTRAPELVIC
LYMPH NODES |
| 201.57 | HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING SPLEEN |
| 201.58 | HODGKIN'S DISEASE NODULAR SCLEROSIS INVOLVING LYMPH NODES
OF MULTIPLE SITES |
| 201.60 | HODGKIN'S DISEASE MIXED CELLULARITY UNSPECIFIED SITE |
| 201.61 | HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING LYMPH NODES
OF HEAD FACE AND NECK |
| 201.62 | HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING INTRATHORACIC
LYMPH NODES |
| 201.63 | HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING
INTRA-ABDOMINAL LYMPH NODES |
| 201.64 | HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING LYMPH NODES
OF AXILLA AND UPPER LIMB |
| 201.65 | HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING LYMPH NODES
OF INGUINAL REGION AND LOWER LIMB |
| 201.66 | HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING INTRAPELVIC
LYMPH NODES |
| 201.67 | HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING SPLEEN |
| 201.68 | HODGKIN'S DISEASE MIXED CELLULARITY INVOLVING LYMPH NODES
OF MULTIPLE SITES |
| 201.70 | HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION UNSPECIFIED SITE |
| 201.71 | HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING LYMPH
NODES OF HEAD FACE AND NECK |
| 201.72 | HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING
INTRATHORACIC LYMPH NODES |
| 201.73 | HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING
INTRA-ABDOMINAL LYMPH NODES |
| 201.74 | HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING LYMPH
NODES OF AXILLA AND UPPER LIMB |
| 201.75 | HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING LYMPH
NODES OF INGUINAL REGION AND LOWER LIMB |
| 201.76 | HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING
INTRAPELVIC LYMPH NODES |
| 201.77 | HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING SPLEEN |
| 201.78 | HODGKIN'S DISEASE LYMPHOCYTIC DEPLETION INVOLVING LYMPH
NODES OF MULTIPLE SITES |
| 201.90 | HODGKIN'S DISEASE UNSPECIFIED TYPE UNSPECIFIED SITE |
| 201.91 | HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING LYMPH NODES OF
HEAD FACE AND NECK |
| 201.92 | HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING INTRATHORACIC
LYMPH NODES |
| 201.93 | HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING
INTRA-ABDOMINAL LYMPH NODES |
| 201.94 | HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING LYMPH NODES OF
AXILLA AND UPPER LIMB |
| 201.95 | HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING LYMPH NODES OF
INGUINAL REGION AND LOWER LIMB |
| 201.96 | HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING INTRAPELVIC
LYMPH NODES |
| 201.97 | HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING SPLEEN |
| 201.98 | HODGKIN'S DISEASE UNSPECIFIED TYPE INVOLVING LYMPH NODES OF
MULTIPLE SITES |
| 202.00 | NODULAR LYMPHOMA UNSPECIFIED SITE |
| 202.01 | NODULAR LYMPHOMA INVOLVING LYMPH NODES OF HEAD FACE AND
NECK |
| 202.02 | NODULAR LYMPHOMA INVOLVING INTRATHORACIC LYMPH NODES |
| 202.03 | NODULAR LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH NODES |
| 202.04 | NODULAR LYMPHOMA INVOLVING LYMPH NODES OF AXILLA AND UPPER
LIMB |
| 202.05 | NODULAR LYMPHOMA INVOLVING LYMPH NODES OF INGUINAL REGION
AND LOWER LIMB |
| 202.06 | NODULAR LYMPHOMA INVOLVING INTRAPELVIC LYMPH NODES |
| 202.07 | NODULAR LYMPHOMA INVOLVING SPLEEN |
| 202.08 | NODULAR LYMPHOMA INVOLVING LYMPH NODES OF MULTIPLE SITES |
| 202.10 | MYCOSIS FUNGOIDES UNSPECIFIED SITE |
| 202.11 | MYCOSIS FUNGOIDES INVOLVING LYMPH NODES OF HEAD FACE AND
NECK |
| 202.12 | MYCOSIS FUNGOIDES INVOLVING INTRATHORACIC LYMPH NODES |
| 202.13 | MYCOSIS FUNGOIDES INVOLVING INTRA-ABDOMINAL LYMPH NODES |
| 202.14 | MYCOSIS FUNGOIDES INVOLVING LYMPH NODES OF AXILLA AND UPPER
LIMB |
| 202.15 | MYCOSIS FUNGOIDES INVOLVING LYMPH NODES OF INGUINAL REGION
AND LOWER LIMB |
| 202.16 | MYCOSIS FUNGOIDES INVOLVING INTRAPELVIC LYMPH NODES |
| 202.17 | MYCOSIS FUNGOIDES INVOLVING SPLEEN |
| 202.18 | MYCOSIS FUNGOIDES INVOLVING LYMPH NODES OF MULTIPLE SITES |
| 202.20 | SEZARY'S DISEASE UNSPECIFIED SITE |
| 202.21 | SEZARY'S DISEASE INVOLVING LYMPH NODES OF HEAD FACE AND
NECK |
| 202.22 | SEZARY'S DISEASE INVOLVING INTRATHORACIC LYMPH NODES |
| 202.23 | SEZARY'S DISEASE INVOLVING INTRA-ABDOMINAL LYMPH NODES |
| 202.24 | SEZARY'S DISEASE INVOLVING LYMPH NODES OF AXILLA AND UPPER
LIMB |
| 202.25 | SEZARY'S DISEASE INVOLVING LYMPH NODES OF INGUINAL REGION
AND LOWER LIMB |
| 202.26 | SEZARY'S DISEASE INVOLVING INTRAPELVIC LYMPH NODES |
| 202.27 | SEZARY'S DISEASE INVOLVING SPLEEN |
| 202.28 | SEZARY'S DISEASE INVOLVING LYMPH NODES OF MULTIPLE SITES |
| 202.30 | MALIGNANT HISTIOCYTOSIS UNSPECIFIED SITE |
| 202.31 | MALIGNANT HISTIOCYTOSIS INVOLVING LYMPH NODES OF HEAD FACE
AND NECK |
| 202.32 | MALIGNANT HISTIOCYTOSIS INVOLVING INTRATHORACIC LYMPH NODES |
| 202.33 | MALIGNANT HISTIOCYTOSIS INVOLVING INTRA-ABDOMINAL LYMPH
NODES |
| 202.34 | MALIGNANT HISTIOCYTOSIS INVOLVING LYMPH NODES OF AXILLA AND
UPPER LIMB |
| 202.35 | MALIGNANT HISTIOCYTOSIS INVOLVING LYMPH NODES OF INGUINAL
REGION AND LOWER LIMB |
| 202.36 | MALIGNANT HISTIOCYTOSIS INVOLVING INTRAPELVIC LYMPH NODES |
| 202.37 | MALIGNANT HISTIOCYTOSIS INVOLVING SPLEEN |
| 202.38 | MALIGNANT HISTIOCYTOSIS INVOLVING LYMPH NODES OF MULTIPLE
SITES |
| 202.40 | LEUKEMIC RETICULOENDOTHELIOSIS UNSPECIFIED SITE |
| 202.41 | LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING LYMPH NODES OF
HEAD FACE AND NECK |
| 202.42 | LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING INTRATHORACIC
LYMPH NODES |
| 202.43 | LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING INTRA-ABDOMINAL
LYMPH NODES |
| 202.44 | LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING LYMPH NODES OF
AXILLA AND UPPER ARM |
| 202.45 | LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING LYMPH NODES OF
INGUINAL REGION AND LOWER LIMB |
| 202.46 | LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING INTRAPELVIC LYMPH
NODES |
| 202.47 | LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING SPLEEN |
| 202.48 | LEUKEMIC RETICULOENDOTHELIOSIS INVOLVING LYMPH NODES OF
MULTIPLE SITES |
| 202.50 | LETTERER-SIWE DISEASE UNSPECIFIED SITE |
| 202.51 | LETTERER-SIWE DISEASE INVOLVING LYMPH NODES OF HEAD FACE
AND NECK |
| 202.52 | LETTERER-SIWE DISEASE INVOLVING INTRATHORACIC LYMPH NODES |
| 202.53 | LETTERER-SIWE DISEASE INVOLVING INTRA-ABDOMINAL LYMPH NODES |
| 202.54 | LETTERER-SIWE DISEASE INVOLVING LYMPH NODES OF AXILLA AND
UPPER LIMB |
| 202.55 | LETTERER-SIWE DISEASE INVOLVING LYMPH NODES OF INGUINAL
REGION AND LOWER LIMB |
| 202.56 | LETTERER-SIWE DISEASE INVOLVING INTRAPELVIC LYMPH NODES |
| 202.57 | LETTERER-SIWE DISEASE INVOLVING SPLEEN |
| 202.58 | LETTERER-SIWE DISEASE INVOLVING LYMPH NODES OF MULTIPLE
SITES |
| 202.60 | MALIGNANT MAST CELL TUMORS UNSPECIFIED SITE |
| 202.61 | MALIGNANT MAST CELL TUMORS INVOLVING LYMPH NODES OF HEAD
FACE AND NECK |
| 202.62 | MALIGNANT MAST CELL TUMORS INVOLVING INTRATHORACIC LYMPH
NODES |
| 202.63 | MALIGNANT MAST CELL TUMORS INVOLVING INTRA-ABDOMINAL LYMPH
NODES |
| 202.64 | MALIGNANT MAST CELL TUMORS INVOLVING LYMPH NODES OF AXILLA
AND UPPER LIMB |
| 202.65 | MALIGNANT MAST CELL TUMORS INVOLVING LYMPH NODES OF
INGUINAL REGION AND LOWER LIMB |
| 202.66 | MALIGNANT MAST CELL TUMORS INVOLVING INTRAPELVIC LYMPH
NODES |
| 202.67 | MALIGNANT MAST CELL TUMORS INVOLVING SPLEEN |
| 202.68 | MALIGNANT MAST CELL TUMORS INVOLVING LYMPH NODES OF
MULTIPLE SITES |
| 202.70 | PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED SITE |
| 202.71 | PERIPHERAL T-CELL LYMPHOMA INVOLVING LYMPH NODES OF HEAD
FACE AND NECK |
| 202.72 | PERIPHERAL T-CELL LYMPHOMA INVOLVING INTRATHORACIC LYMPH
NODES |
| 202.73 | PERIPHERAL T-CELL LYMPHOMA INVOLVING INTRA-ABDOMINAL LYMPH
NODES |
| 202.74 | PERIPHERAL T-CELL LYMPHOMA INVOLVING LYMPH NODES OF AXILLA
AND UPPER LIMB |
| 202.75 | PERIPHERAL T-CELL LYMPHOMA INVOLVING LYMPH NODES OF
INGUINAL REGION AND LOWER LIMB |
| 202.76 | PERIPHERAL T-CELL LYMPHOMA INVOLVING INTRAPELVIC LYMPH
NODES |
| 202.77 | PERIPHERAL T-CELL LYMPHOMA INVOLVING SPLEEN |
| 202.78 | PERIPHERAL T-CELL LYMPHOMA INVOLVING LYMPH NODES OF
MULTIPLE SITES |
| 202.80 | OTHER MALIGNANT LYMPHOMAS UNSPECIFIED SITE |
| 202.81 | OTHER MALIGNANT LYMPHOMAS INVOLVING LYMPH NODES OF HEAD
FACE AND NECK |
| 202.82 | OTHER MALIGNANT LYMPHOMAS INVOLVING INTRATHORACIC LYMPH
NODES |
| 202.83 | OTHER MALIGNANT LYMPHOMAS INVOLVING INTRA-ABDOMINAL LYMPH
NODES |
| 202.84 | OTHER MALIGNANT LYMPHOMAS INVOLVING LYMPH NODES OF AXILLA
AND UPPER LIMB |
| 202.85 | OTHER MALIGNANT LYMPHOMAS INVOLVING LYMPH NODES OF INGUINAL
REGION AND LOWER LIMB |
| 202.86 | OTHER MALIGNANT LYMPHOMAS INVOLVING INTRAPELVIC LYMPH NODES |
| 202.87 | OTHER MALIGNANT LYMPHOMAS INVOLVING SPLEEN |
| 202.88 | OTHER MALIGNANT LYMPHOMAS INVOLVING LYMPH NODES OF MULTIPLE
SITES |
| 202.90 | OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND
HISTIOCYTIC TISSUE UNSPECIFIED SITE |
| 202.91 | OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND
HISTIOCYTIC TISSUE INVOLVING LYMPH NODES OF HEAD FACE AND
NECK |
| 202.92 | OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND
HISTIOCYTIC TISSUE INVOLVING INTRATHORACIC LYMPH NODES |
| 202.93 | OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND
HISTIOCYTIC TISSUE INVOLVING INTRA-ABDOMINAL LYMPH NODES |
| 202.94 | OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND
HISTIOCYTIC TISSUE INVOLVING LYMPH NODES OF AXILLA AND
UPPER LIMB |
| 202.95 | OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND
HISTIOCYTIC TISSUE INVOLVING LYMPH NODES OF INGUINAL REGION
AND LOWER LIMB |
| 202.96 | OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND
HISTIOCYTIC TISSUE INVOLVING INTRAPELVIC LYMPH NODES |
| 202.97 | OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND
HISTIOCYTIC TISSUE INVOLVING SPLEEN |
| 202.98 | OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS OF LYMPHOID AND
HISTIOCYTIC TISSUE INVOLVING LYMPH NODES OF MULTIPLE SITES |
| 203.00 | MULTIPLE MYELOMA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 203.01 | MULTIPLE MYELOMA IN REMISSION |
| 203.02 | MULTIPLE MYELOMA IN RELAPSE |
| 203.10 | PLASMA CELL LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 203.11 | PLASMA CELL LEUKEMIA IN REMISSION |
| 203.12 | PLASMA CELL LEUKEMIA IN RELAPSE |
| 203.80 | OTHER IMMUNOPROLIFERATIVE NEOPLASMS WITHOUT MENTION OF
HAVING ACHIEVED REMISSION |
| 203.81 | OTHER IMMUNOPROLIFERATIVE NEOPLASMS IN REMISSION |
| 203.82 | OTHER IMMUNOPROLIFERATIVE NEOPLASMS IN RELAPSE |
| 204.00 | ACUTE LYMPHOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 204.01 | ACUTE LYMPHOID LEUKEMIA IN REMISSION |
| 204.02 | ACUTE LYMPHOID LEUKEMIA IN RELAPSE |
| 204.10 | CHRONIC LYMPHOID LEUKEMIA WITHOUT MENTION OF HAVING
ACHIEVED REMISSION |
| 204.11 | CHRONIC LYMPHOID LEUKEMIA IN REMISSION |
| 204.12 | CHRONIC LYMPHOID LEUKEMIA IN RELAPSE |
| 204.20 | SUBACUTE LYMPHOID LEUKEMIA WITHOUT MENTION OF HAVING
ACHIEVED REMISSION |
| 204.21 | SUBACUTE LYMPHOID LEUKEMIA IN REMISSION |
| 204.22 | SUBACUTE LYMPHOID LEUKEMIA IN RELAPSE |
| 204.80 | OTHER LYMPHOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 204.81 | OTHER LYMPHOID LEUKEMIA IN REMISSION |
| 204.82 | OTHER LYMPHOID LEUKEMIA IN RELAPSE |
| 204.90 | UNSPECIFIED LYMPHOID LEUKEMIA WITHOUT MENTION OF HAVING
ACHIEVED REMISSION |
| 204.91 | UNSPECIFIED LYMPHOID LEUKEMIA IN REMISSION |
| 204.92 | UNSPECIFIED LYMPHOID LEUKEMIA IN RELAPSE |
| 205.00 | ACUTE MYELOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 205.01 | ACUTE MYELOID LEUKEMIA IN REMISSION |
| 205.02 | ACUTE MYELOID LEUKEMIA IN RELAPSE |
| 205.10 | CHRONIC MYELOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 205.11 | CHRONIC MYELOID LEUKEMIA IN REMISSION |
| 205.12 | CHRONIC MYELOID LEUKEMIA IN RELAPSE |
| 205.20 | SUBACUTE MYELOID LEUKEMIA WITHOUT MENTION OF HAVING
ACHIEVED REMISSION |
| 205.21 | SUBACUTE MYELOID LEUKEMIA IN REMISSION |
| 205.22 | SUBACUTE MYELOID LEUKEMIA IN RELAPSE |
| 205.30 | MYELOID SARCOMA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 205.31 | MYELOID SARCOMA IN REMISSION |
| 205.32 | MYELOID SARCOMA IN RELAPSE |
| 205.80 | OTHER MYELOID LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 205.81 | OTHER MYELOID LEUKEMIA IN REMISSION |
| 205.82 | OTHER MYELOID LEUKEMIA IN RELAPSE |
| 205.90 | UNSPECIFIED MYELOID LEUKEMIA WITHOUT MENTION OF HAVING
ACHIEVED REMISSION |
| 205.91 | UNSPECIFIED MYELOID LEUKEMIA IN REMISSION |
| 205.92 | UNSPECIFIED MYELOID LEUKEMIA IN RELAPSE |
| 206.00 | ACUTE MONOCYTIC LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 206.01 | ACUTE MONOCYTIC LEUKEMIA IN REMISSION |
| 206.02 | ACUTE MONOCYTIC LEUKEMIA IN RELAPSE |
| 206.10 | CHRONIC MONOCYTIC LEUKEMIA WITHOUT MENTION OF HAVING
ACHIEVED REMISSION |
| 206.11 | CHRONIC MONOCYTIC LEUKEMIA IN REMISSION |
| 206.12 | CHRONIC MONOCYTIC LEUKEMIA IN RELAPSE |
| 206.20 | SUBACUTE MONOCYTIC LEUKEMIA WITHOUT MENTION OF HAVING
ACHIEVED REMISSION |
| 206.21 | SUBACUTE MONOCYTIC LEUKEMIA IN REMISSION |
| 206.22 | SUBACUTE MONOCYTIC LEUKEMIA IN RELAPSE |
| 206.80 | OTHER MONOCYTIC LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 206.81 | OTHER MONOCYTIC LEUKEMIA IN REMISSION |
| 206.82 | OTHER MONOCYTIC LEUKEMIA IN RELAPSE |
| 206.90 | UNSPECIFIED MONOCYTIC LEUKEMIA WITHOUT MENTION OF HAVING
ACHIEVED REMISSION |
| 206.91 | UNSPECIFIED MONOCYTIC LEUKEMIA IN REMISSION |
| 206.92 | UNSPECIFIED MONOCYTIC LEUKEMIA IN RELAPSE |
| 207.00 | ACUTE ERYTHREMIA AND ERYTHROLEUKEMIA WITHOUT MENTION OF
HAVING ACHIEVED REMISSION |
| 207.01 | ACUTE ERYTHREMIA AND ERYTHROLEUKEMIA IN REMISSION |
| 207.02 | ACUTE ERYTHREMIA AND ERYTHROLEUKEMIA IN RELAPSE |
| 207.10 | CHRONIC ERYTHREMIA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 207.11 | CHRONIC ERYTHREMIA IN REMISSION |
| 207.12 | CHRONIC ERYTHREMIA IN RELAPSE |
| 207.20 | MEGAKARYOCYTIC LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 207.21 | MEGAKARYOCYTIC LEUKEMIA IN REMISSION |
| 207.22 | MEGAKARYOCYTIC LEUKEMIA IN RELAPSE |
| 207.80 | OTHER SPECIFIED LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 207.81 | OTHER SPECIFIED LEUKEMIA IN REMISSION |
| 207.82 | OTHER SPECIFIED LEUKEMIA IN RELAPSE |
| 208.00 | ACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE WITHOUT MENTION OF
HAVING ACHIEVED REMISSION |
| 208.01 | ACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE IN REMISSION |
| 208.02 | ACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE IN RELAPSE |
| 208.10 | CHRONIC LEUKEMIA OF UNSPECIFIED CELL TYPE WITHOUT MENTION
OF HAVING ACHIEVED REMISSION |
| 208.11 | CHRONIC LEUKEMIA OF UNSPECIFIED CELL TYPE IN REMISSION |
| 208.12 | CHRONIC LEUKEMIA OF UNSPECIFIED CELL TYPE IN RELAPSE |
| 208.20 | SUBACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE WITHOUT MENTION
OF HAVING ACHIEVED REMISSION |
| 208.21 | SUBACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE IN REMISSION |
| 208.22 | SUBACUTE LEUKEMIA OF UNSPECIFIED CELL TYPE IN RELAPSE |
| 208.80 | OTHER LEUKEMIA OF UNSPECIFIED CELL TYPE WITHOUT MENTION OF
HAVING ACHIEVED REMISSION |
| 208.81 | OTHER LEUKEMIA OF UNSPECIFIED CELL TYPE IN REMISSION |
| 208.82 | OTHER LEUKEMIA OF UNSPECIFIED CELL TYPE IN RELAPSE |
| 208.90 | UNSPECIFIED LEUKEMIA WITHOUT MENTION OF HAVING ACHIEVED
REMISSION |
| 208.91 | UNSPECIFIED LEUKEMIA IN REMISSION |
| 208.92 | UNSPECIFIED LEUKEMIA IN RELAPSE |
| 209.20 | MALIGNANT CARCINOID TUMOR OF UNKNOWN PRIMARY SITE |
| 209.21 | MALIGNANT CARCINOID TUMOR OF THE BRONCHUS AND LUNG |
| 209.22 | MALIGNANT CARCINOID TUMOR OF THE THYMUS |
| 209.23 | MALIGNANT CARCINOID TUMOR OF THE STOMACH |
| 209.24 | MALIGNANT CARCINOID TUMOR OF THE KIDNEY |
| 209.25 | MALIGNANT CARCINOID TUMOR OF THE FOREGUT NOT OTHERWISE
SPECIFIED |
| 209.26 | MALIGNANT CARCINOID TUMOR OF THE MIDGUT NOT OTHERWISE
SPECIFIED |
| 209.27 | MALIGNANT CARCINOID TUMOR OF THE HINDGUT NOT OTHERWISE
SPECIFIED |
| 209.29 | MALIGNANT CARCINOID TUMOR OF OTHER SITES |
| 211.5 | BENIGN NEOPLASM OF LIVER AND BILIARY PASSAGES |
| 211.6 | BENIGN NEOPLASM OF PANCREAS EXCEPT ISLETS OF LANGERHANS |
| 211.7 | BENIGN NEOPLASM OF ISLETS OF LANGERHANS |
| 228.04 | HEMANGIOMA OF INTRA-ABDOMINAL STRUCTURES |
| 230.7 | CARCINOMA IN SITU OF OTHER AND UNSPECIFIED PARTS OF
INTESTINE |
| 230.8 | CARCINOMA IN SITU OF LIVER AND BILIARY SYSTEM |
| 230.9 | CARCINOMA IN SITU OF OTHER AND UNSPECIFIED DIGESTIVE ORGANS |
| 235.0 | NEOPLASM OF UNCERTAIN BEHAVIOR OF MAJOR SALIVARY GLANDS |
| 235.1 | NEOPLASM OF UNCERTAIN BEHAVIOR OF LIP ORAL CAVITY AND
PHARYNX |
| 235.2 | NEOPLASM OF UNCERTAIN BEHAVIOR OF STOMACH INTESTINES AND
RECTUM |
| 235.3 | NEOPLASM OF UNCERTAIN BEHAVIOR OF LIVER AND BILIARY
PASSAGES |
| 235.4 | NEOPLASM OF UNCERTAIN BEHAVIOR OF RETROPERITONEUM AND
PERITONEUM |
| 235.5 | NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED
DIGESTIVE ORGANS |
| 235.6 | NEOPLASM OF UNCERTAIN BEHAVIOR OF LARYNX |
| 235.7 | NEOPLASM OF UNCERTAIN BEHAVIOR OF TRACHEA BRONCHUS AND LUNG |
| 235.8 | NEOPLASM OF UNCERTAIN BEHAVIOR OF PLEURA THYMUS AND
MEDIASTINUM |
| 235.9 | NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED
RESPIRATORY ORGANS |
| 236.0 | NEOPLASM OF UNCERTAIN BEHAVIOR OF UTERUS |
| 236.1 | NEOPLASM OF UNCERTAIN BEHAVIOR OF PLACENTA |
| 236.2 | NEOPLASM OF UNCERTAIN BEHAVIOR OF OVARY |
| 236.3 | NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED
FEMALE GENITAL ORGANS |
| 236.4 | NEOPLASM OF UNCERTAIN BEHAVIOR OF TESTIS |
| 236.5 | NEOPLASM OF UNCERTAIN BEHAVIOR OF PROSTATE |
| 236.6 | NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED
MALE GENITAL ORGANS |
| 236.7 | NEOPLASM OF UNCERTAIN BEHAVIOR OF BLADDER |
| 236.90 | NEOPLASM OF UNCERTAIN BEHAVIOR OF URINARY ORGAN UNSPECIFIED |
| 236.91 | NEOPLASM OF UNCERTAIN BEHAVIOR OF KIDNEY AND URETER |
| 236.99 | NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED
URINARY ORGANS |
| 237.0 | NEOPLASM OF UNCERTAIN BEHAVIOR OF PITUITARY GLAND AND
CRANIOPHARYNGEAL DUCT |
| 237.1 | NEOPLASM OF UNCERTAIN BEHAVIOR OF PINEAL GLAND |
| 237.2 | NEOPLASM OF UNCERTAIN BEHAVIOR OF ADRENAL GLAND |
| 237.3 | NEOPLASM OF UNCERTAIN BEHAVIOR OF PARAGANGLIA |
| 237.4 | NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED
ENDOCRINE GLANDS |
| 237.5 | NEOPLASM OF UNCERTAIN BEHAVIOR OF BRAIN AND SPINAL CORD |
| 237.6 | NEOPLASM OF UNCERTAIN BEHAVIOR OF MENINGES |
| 237.70 | NEUROFIBROMATOSIS UNSPECIFIED |
| 237.71 | NEUROFIBROMATOSIS TYPE 1 VON RECKLINGHAUSEN'S DISEASE |
| 237.72 | NEUROFIBROMATOSIS TYPE 2 ACOUSTIC NEUROFIBROMATOSIS |
| 237.9 | NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER AND UNSPECIFIED
PARTS OF NERVOUS SYSTEM |
| 238.0 | NEOPLASM OF UNCERTAIN BEHAVIOR OF BONE AND ARTICULAR
CARTILAGE |
| 238.1 | NEOPLASM OF UNCERTAIN BEHAVIOR OF CONNECTIVE AND OTHER SOFT
TISSUE |
| 238.2 | NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN |
| 238.3 | NEOPLASM OF UNCERTAIN BEHAVIOR OF BREAST |
| 238.4 | POLYCYTHEMIA VERA |
| 238.5 | NEOPLASM OF UNCERTAIN BEHAVIOR OF HISTIOCYTIC AND MAST
CELLS |
| 238.6 | NEOPLASM OF UNCERTAIN BEHAVIOR OF PLASMA CELLS |
| 238.71 | ESSENTIAL THROMBOCYTHEMIA |
| 238.72 | LOW GRADE MYELODYSPLASTIC SYNDROME LESIONS |
| 238.73 | HIGH GRADE MYELODYSPLASTIC SYNDROME LESIONS |
| 238.74 | MYELODYSPLASTIC SYNDROME WITH 5Q DELETION |
| 238.75 | MYELODYSPLASTIC SYNDROME UNSPECIFIED |
| 238.76 | MYELOFIBROSIS WITH MYELOID METAPLASIA |
| 238.77 | POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) |
| 238.79 | NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER LYMPHATIC AND
HEMATOPOIETIC TISSUES |
| 238.8 | NEOPLASM OF UNCERTAIN BEHAVIOR OF OTHER SPECIFIED SITES |
| 238.9 | NEOPLASM OF UNCERTAIN BEHAVIOR SITE UNSPECIFIED |
| 239.0 | NEOPLASM OF UNSPECIFIED NATURE OF DIGESTIVE SYSTEM |
| 250.00 | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION TYPE II
OR UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED |
| 250.01 | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION TYPE I
[JUVENILE TYPE] NOT STATED AS UNCONTROLLED |
| 250.02 | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION TYPE II
OR UNSPECIFIED TYPE UNCONTROLLED |
| 250.03 | DIABETES MELLITUS WITHOUT MENTION OF COMPLICATION TYPE I
[JUVENILE TYPE] UNCONTROLLED |
| 250.10 | DIABETES WITH KETOACIDOSIS TYPE II OR UNSPECIFIED TYPE NOT
STATED AS UNCONTROLLED |
| 250.11 | DIABETES WITH KETOACIDOSIS TYPE I [JUVENILE TYPE] NOT
STATED AS UNCONTROLLED |
| 250.12 | DIABETES WITH KETOACIDOSIS TYPE II OR UNSPECIFIED TYPE
UNCONTROLLED |
| 250.13 | DIABETES WITH KETOACIDOSIS TYPE I [JUVENILE TYPE]
UNCONTROLLED |
| 250.20 | DIABETES WITH HYPEROSMOLARITY TYPE II OR UNSPECIFIED TYPE
NOT STATED AS UNCONTROLLED |
| 250.21 | DIABETES WITH HYPEROSMOLARITY TYPE I [JUVENILE TYPE] NOT
STATED AS UNCONTROLLED |
| 250.22 | DIABETES WITH HYPEROSMOLARITY TYPE II OR UNSPECIFIED TYPE
UNCONTROLLED |
| 250.23 | DIABETES WITH HYPEROSMOLARITY TYPE I [JUVENILE TYPE]
UNCONTROLLED |
| 250.30 | DIABETES WITH OTHER COMA TYPE II OR UNSPECIFIED TYPE NOT
STATED AS UNCONTROLLED |
| 250.31 | DIABETES WITH OTHER COMA TYPE I [JUVENILE TYPE] NOT STATED
AS UNCONTROLLED |
| 250.32 | DIABETES WITH OTHER COMA TYPE II OR UNSPECIFIED TYPE
UNCONTROLLED |
| 250.33 | DIABETES WITH OTHER COMA TYPE I [JUVENILE TYPE]
UNCONTROLLED |
| 250.40 | DIABETES WITH RENAL MANIFESTATIONS TYPE II OR UNSPECIFIED
TYPE NOT STATED AS UNCONTROLLED |
| 250.41 | DIABETES WITH RENAL MANIFESTATIONS TYPE I [JUVENILE TYPE]
NOT STATED AS UNCONTROLLED |
| 250.42 | DIABETES WITH RENAL MANIFESTATIONS TYPE II OR UNSPECIFIED
TYPE UNCONTROLLED |
| 250.43 | DIABETES WITH RENAL MANIFESTATIONS TYPE I [JUVENILE TYPE]
UNCONTROLLED |
| 250.50 | DIABETES WITH OPHTHALMIC MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED |
| 250.51 | DIABETES WITH OPHTHALMIC MANIFESTATIONS TYPE I [JUVENILE
TYPE] NOT STATED AS UNCONTROLLED |
| 250.52 | DIABETES WITH OPHTHALMIC MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE UNCONTROLLED |
| 250.53 | DIABETES WITH OPHTHALMIC MANIFESTATIONS TYPE I [JUVENILE
TYPE] UNCONTROLLED |
| 250.60 | DIABETES WITH NEUROLOGICAL MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED |
| 250.61 | DIABETES WITH NEUROLOGICAL MANIFESTATIONS TYPE I [JUVENILE
TYPE] NOT STATED AS UNCONTROLLED |
| 250.62 | DIABETES WITH NEUROLOGICAL MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE UNCONTROLLED |
| 250.63 | DIABETES WITH NEUROLOGICAL MANIFESTATIONS TYPE I [JUVENILE
TYPE] UNCONTROLLED |
| 250.70 | DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS TYPE II OR
UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED |
| 250.71 | DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS TYPE I
[JUVENILE TYPE] NOT STATED AS UNCONTROLLED |
| 250.72 | DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS TYPE II OR
UNSPECIFIED TYPE UNCONTROLLED |
| 250.73 | DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS TYPE I
[JUVENILE TYPE] UNCONTROLLED |
| 250.80 | DIABETES WITH OTHER SPECIFIED MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED |
| 250.81 | DIABETES WITH OTHER SPECIFIED MANIFESTATIONS TYPE I
[JUVENILE TYPE] NOT STATED AS UNCONTROLLED |
| 250.82 | DIABETES WITH OTHER SPECIFIED MANIFESTATIONS TYPE II OR
UNSPECIFIED TYPE UNCONTROLLED |
| 250.83 | DIABETES WITH OTHER SPECIFIED MANIFESTATIONS TYPE I
[JUVENILE TYPE] UNCONTROLLED |
| 250.90 | DIABETES WITH UNSPECIFIED COMPLICATION TYPE II OR
UNSPECIFIED TYPE NOT STATED AS UNCONTROLLED |
| 250.91 | DIABETES WITH UNSPECIFIED COMPLICATION TYPE I [JUVENILE
TYPE] NOT STATED AS UNCONTROLLED |
| 250.92 | DIABETES WITH UNSPECIFIED COMPLICATION TYPE II OR
UNSPECIFIED TYPE UNCONTROLLED |
| 250.93 | DIABETES WITH UNSPECIFIED COMPLICATION TYPE I [JUVENILE
TYPE] UNCONTROLLED |
| 252.00 | HYPERPARATHYROIDISM UNSPECIFIED |
| 252.01 | PRIMARY HYPERPARATHYROIDISM |
| 252.02 | SECONDARY HYPERPARATHYROIDISM NONRENAL |
| 252.08 | OTHER HYPERPARATHYROIDISM |
| 263.1 | MALNUTRITION OF MILD DEGREE |
| 263.9 | UNSPECIFIED PROTEIN-CALORIE MALNUTRITION |
| 268.0 | RICKETS ACTIVE |
| 268.2 | OSTEOMALACIA UNSPECIFIED |
| 269.0 | DEFICIENCY OF VITAMIN K |
| 270.2 | OTHER DISTURBANCES OF AROMATIC AMINO-ACID METABOLISM |
| 270.9 | UNSPECIFIED DISORDER OF AMINO-ACID METABOLISM |
| 271.0 | GLYCOGENOSIS |
| 272.0 | PURE HYPERCHOLESTEROLEMIA |
| 272.1 | PURE HYPERGLYCERIDEMIA |
| 272.2 | MIXED HYPERLIPIDEMIA |
| 272.4 | OTHER AND UNSPECIFIED HYPERLIPIDEMIA |
| 272.7 | LIPIDOSES |
| 272.9 | UNSPECIFIED DISORDER OF LIPOID METABOLISM |
| 273.4 | ALPHA-1-ANTITRYPSIN DEFICIENCY |
| 275.0 | DISORDERS OF IRON METABOLISM |
| 275.1 | DISORDERS OF COPPER METABOLISM |
| 275.2 | DISORDERS OF MAGNESIUM METABOLISM |
| 275.3 | DISORDERS OF PHOSPHORUS METABOLISM |
| 275.40 | UNSPECIFIED DISORDER OF CALCIUM METABOLISM |
| 275.41 | HYPOCALCEMIA |
| 275.42 | HYPERCALCEMIA |
| 275.49 | OTHER DISORDERS OF CALCIUM METABOLISM |
| 275.5 | HUNGRY BONE SYNDROME |
| 277.1 | DISORDERS OF PORPHYRIN METABOLISM |
| 277.30 | AMYLOIDOSIS UNSPECIFIED |
| 277.31 | FAMILIAL MEDITERRANEAN FEVER |
| 277.39 | OTHER AMYLOIDOSIS |
| 277.4 | DISORDERS OF BILIRUBIN EXCRETION |
| 277.6 | OTHER DEFICIENCIES OF CIRCULATING ENZYMES |
| 282.60 | SICKLE-CELL DISEASE UNSPECIFIED |
| 282.61 | HB-SS DISEASE WITHOUT CRISIS |
| 282.62 | HB-SS DISEASE WITH CRISIS |
| 282.63 | SICKLE-CELL/HB-C DISEASE WITHOUT CRISIS |
| 282.64 | SICKLE-CELL/HB C DISEASE WITH CRISIS |
| 282.68 | OTHER SICKLE-CELL DISEASE WITHOUT CRISIS |
| 282.69 | OTHER SICKLE-CELL DISEASE WITH CRISIS |
| 286.6 | DEFIBRINATION SYNDROME |
| 286.7 | ACQUIRED COAGULATION FACTOR DEFICIENCY |
| 289.4 | HYPERSPLENISM |
| 289.52 | SPLENIC SEQUESTRATION |
| 291.0 | ALCOHOL WITHDRAWAL DELIRIUM |
| 291.1 | ALCOHOL-INDUCED PERSISTING AMNESTIC DISORDER |
| 291.2 | ALCOHOL-INDUCED PERSISTING DEMENTIA |
| 291.3 | ALCOHOL-INDUCED PSYCHOTIC DISORDER WITH HALLUCINATIONS |
| 291.4 | IDIOSYNCRATIC ALCOHOL INTOXICATION |
| 291.5 | ALCOHOL-INDUCED PSYCHOTIC DISORDER WITH DELUSIONS |
| 291.81 | ALCOHOL WITHDRAWAL |
| 291.82 | ALCOHOL-INDUCED SLEEP DISORDERS |
| 291.89 | OTHER SPECIFIED ALCOHOL-INDUCED MENTAL DISORDERS |
| 291.9 | UNSPECIFIED ALCOHOL-INDUCED MENTAL DISORDERS |
| 303.00 | ACUTE ALCOHOLIC INTOXICATION IN ALCOHOLISM UNSPECIFIED
DRINKING BEHAVIOR |
| 303.01 | ACUTE ALCOHOLIC INTOXICATION IN ALCOHOLISM CONTINUOUS
DRINKING BEHAVIOR |
| 303.02 | ACUTE ALCOHOLIC INTOXICATION IN ALCOHOLISM EPISODIC
DRINKING BEHAVIOR |
| 303.03 | ACUTE ALCOHOLIC INTOXICATION IN ALCOHOLISM IN REMISSION |
| 303.90 | OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE UNSPECIFIED
DRINKING BEHAVIOR |
| 303.91 | OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE CONTINUOUS
DRINKING BEHAVIOR |
| 303.92 | OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE EPISODIC DRINKING
BEHAVIOR |
| 303.93 | OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE IN REMISSION |
| 304.00 | OPIOID TYPE DEPENDENCE UNSPECIFIED USE |
| 304.01 | OPIOID TYPE DEPENDENCE CONTINUOUS USE |
| 304.02 | OPIOID TYPE DEPENDENCE EPISODIC USE |
| 304.03 | OPIOID TYPE DEPENDENCE IN REMISSION |
| 304.10 | "SEDATIVE, HYPNOTIC OR ANXIOLYTIC DEPENDENCE UNSPECIFIED
USE" |
| 304.11 | "SEDATIVE, HYPNOTIC OR ANXIOLYTIC DEPENDENCE CONTINUOUS
USE" |
| 304.12 | "SEDATIVE, HYPNOTIC OR ANXIOLYTIC DEPENDENCE EPISODIC USE" |
| 304.13 | "SEDATIVE, HYPNOTIC OR ANXIOLYTIC DEPENDENCE IN REMISSION" |
| 304.20 | COCAINE DEPENDENCE UNSPECIFIED USE |
| 304.21 | COCAINE DEPENDENCE CONTINUOUS USE |
| 304.22 | COCAINE DEPENDENCE EPISODIC USE |
| 304.23 | COCAINE DEPENDENCE IN REMISSION |
| 304.30 | CANNABIS DEPENDENCE UNSPECIFIED USE |
| 304.31 | CANNABIS DEPENDENCE CONTINUOUS USE |
| 304.32 | CANNABIS DEPENDENCE EPISODIC USE |
| 304.33 | CANNABIS DEPENDENCE IN REMISSION |
| 304.40 | AMPHETAMINE AND OTHER PSYCHOSTIMULANT DEPENDENCE
UNSPECIFIED USE |
| 304.41 | AMPHETAMINE AND OTHER PSYCHOSTIMULANT DEPENDENCE CONTINUOUS
USE |
| 304.42 | AMPHETAMINE AND OTHER PSYCHOSTIMULANT DEPENDENCE EPISODIC
USE |
| 304.43 | AMPHETAMINE AND OTHER PSYCHOSTIMULANT DEPENDENCE IN
REMISSION |
| 304.50 | HALLUCINOGEN DEPENDENCE UNSPECIFIED USE |
| 304.51 | HALLUCINOGEN DEPENDENCE CONTINUOUS USE |
| 304.52 | HALLUCINOGEN DEPENDENCE EPISODIC USE |
| 304.53 | HALLUCINOGEN DEPENDENCE IN REMISSION |
| 304.60 | OTHER SPECIFIED DRUG DEPENDENCE UNSPECIFIED USE |
| 304.61 | OTHER SPECIFIED DRUG DEPENDENCE CONTINUOUS USE |
| 304.62 | OTHER SPECIFIED DRUG DEPENDENCE EPISODIC USE |
| 304.63 | OTHER SPECIFIED DRUG DEPENDENCE IN REMISSION |
| 304.70 | COMBINATIONS OF OPIOID TYPE DRUG WITH ANY OTHER DRUG
DEPENDENCE UNSPECIFIED USE |
| 304.71 | COMBINATIONS OF OPIOID TYPE DRUG WITH ANY OTHER DRUG
DEPENDENCE CONTINUOUS USE |
| 304.72 | COMBINATIONS OF OPIOID TYPE DRUG WITH ANY OTHER DRUG
DEPENDENCE EPISODIC USE |
| 304.73 | COMBINATIONS OF OPIOID TYPE DRUG WITH ANY OTHER DRUG
DEPENDENCE IN REMISSION |
| 304.80 | COMBINATIONS OF DRUG DEPENDENCE EXCLUDING OPIOID TYPE DRUG
UNSPECIFIED USE |
| 304.81 | COMBINATIONS OF DRUG DEPENDENCE EXCLUDING OPIOID TYPE DRUG
CONTINUOUS USE |
| 304.82 | COMBINATIONS OF DRUG DEPENDENCE EXCLUDING OPIOID TYPE DRUG
EPISODIC USE |
| 304.83 | COMBINATIONS OF DRUG DEPENDENCE EXCLUDING OPIOID TYPE DRUG
IN REMISSION |
| 304.90 | UNSPECIFIED DRUG DEPENDENCE UNSPECIFIED USE |
| 304.91 | UNSPECIFIED DRUG DEPENDENCE CONTINUOUS USE |
| 304.92 | UNSPECIFIED DRUG DEPENDENCE EPISODIC USE |
| 304.93 | UNSPECIFIED DRUG DEPENDENCE IN REMISSION |
| 305.00 | NONDEPENDENT ALCOHOL ABUSE UNSPECIFIED DRINKING BEHAVIOR |
| 305.01 | NONDEPENDENT ALCOHOL ABUSE CONTINUOUS DRINKING BEHAVIOR |
| 305.02 | NONDEPENDENT ALCOHOL ABUSE EPISODIC DRINKING BEHAVIOR |
| 305.03 | NONDEPENDENT ALCOHOL ABUSE IN REMISSION |
| 305.1 | NONDEPENDENT TOBACCO USE DISORDER |
| 305.20 | NONDEPENDENT CANNABIS ABUSE UNSPECIFIED USE |
| 305.21 | NONDEPENDENT CANNABIS ABUSE CONTINUOUS USE |
| 305.22 | NONDEPENDENT CANNABIS ABUSE EPISODIC USE |
| 305.23 | NONDEPENDENT CANNABIS ABUSE IN REMISSION |
| 305.30 | NONDEPENDENT HALLUCINOGEN ABUSE UNSPECIFIED USE |
| 305.31 | NONDEPENDENT HALLUCINOGEN ABUSE CONTINUOUS USE |
| 305.32 | NONDEPENDENT HALLUCINOGEN ABUSE EPISODIC USE |
| 305.33 | NONDEPENDENT HALLUCINOGEN ABUSE IN REMISSION |
| 305.40 | "NONDEPENDENT SEDATIVE, HYPNOTIC OR ANXIOLYTIC ABUSE
UNSPECIFIED USE" |
| 305.41 | "NONDEPENDENT SEDATIVE, HYPNOTIC OR ANXIOLYTIC ABUSE
CONTINUOUS USE" |
| 305.42 | "NONDEPENDENT SEDATIVE, HYPNOTIC OR ANXIOLYTIC ABUSE
EPISODIC USE" |
| 305.43 | "NONDEPENDENT SEDATIVE, HYPNOTIC OR ANXIOLYTIC ABUSE IN
REMISSION" |
| 305.50 | NONDEPENDENT OPIOID ABUSE UNSPECIFIED USE |
| 305.51 | NONDEPENDENT OPIOID ABUSE CONTINUOUS USE |
| 305.52 | NONDEPENDENT OPIOID ABUSE EPISODIC USE |
| 305.53 | NONDEPENDENT OPIOID ABUSE IN REMISSION |
| 305.60 | NONDEPENDENT COCAINE ABUSE UNSPECIFIED USE |
| 305.61 | NONDEPENDENT COCAINE ABUSE CONTINUOUS USE |
| 305.62 | NONDEPENDENT COCAINE ABUSE EPISODIC USE |
| 305.63 | NONDEPENDENT COCAINE ABUSE IN REMISSION |
| 305.70 | NONDEPENDENT AMPHETAMINE OR RELATED ACTING SYMPATHOMIMETIC
ABUSE UNSPECIFIED USE |
| 305.71 | NONDEPENDENT AMPHETAMINE OR RELATED ACTING SYMPATHOMIMETIC
ABUSE CONTINUOUS USE |
| 305.72 | NONDEPENDENT AMPHETAMINE OR RELATED ACTING SYMPATHOMIMETIC
ABUSE EPISODIC USE |
| 305.73 | NONDEPENDENT AMPHETAMINE OR RELATED ACTING SYMPATHOMIMETIC
ABUSE IN REMISSION |
| 305.80 | NONDEPENDENT ANTIDEPRESSANT TYPE ABUSE UNSPECIFIED USE |
| 305.81 | NONDEPENDENT ANTIDEPRESSANT TYPE ABUSE CONTINUOUS USE |
| 305.82 | NONDEPENDENT ANTIDEPRESSANT TYPE ABUSE EPISODIC USE |
| 305.83 | NONDEPENDENT ANTIDEPRESSANT TYPE ABUSE IN REMISSION |
| 305.90 | OTHER MIXED OR UNSPECIFIED DRUG ABUSE UNSPECIFIED USE |
| 305.91 | NONDEPENDENT OTHER MIXED OR UNSPECIFIED DRUG ABUSE
CONTINUOUS USE |
| 305.92 | NONDEPENDENT OTHER MIXED OR UNSPECIFIED DRUG ABUSE EPISODIC
USE |
| 305.93 | NONDEPENDENT OTHER MIXED OR UNSPECIFIED DRUG ABUSE IN
REMISSION |
| 357.5 | ALCOHOLIC POLYNEUROPATHY |
| 359.21 | MYOTONIC MUSCULAR DYSTROPHY |
| 359.22 | MYOTONIA CONGENITA |
| 359.23 | MYOTONIC CHONDRODYSTROPHY |
| 359.24 | DRUG-INDUCED MYOTONIA |
| 359.29 | OTHER SPECIFIED MYOTONIC DISORDER |
| 452 | PORTAL VEIN THROMBOSIS |
| 453.0 | BUDD-CHIARI SYNDROME |
| 453.1 | THROMBOPHLEBITIS MIGRANS |
| 453.2 | EMBOLISM AND THROMBOSIS OF VENA CAVA |
| 453.3 | EMBOLISM AND THROMBOSIS OF RENAL VEIN |
| 453.40 | VENOUS EMBOLISM AND THROMBOSIS OF UNSPECIFIED DEEP VESSELS
OF LOWER EXTREMITY |
| 453.41 | VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF PROXIMAL
LOWER EXTREMITY |
| 453.42 | VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF DISTAL
LOWER EXTREMITY |
| 453.8 | EMBOLISM AND THROMBOSIS OF OTHER SPECIFIED VEINS |
| 453.9 | EMBOLISM AND THROMBOSIS OF UNSPECIFIED SITE |
| 453.40 | VENOUS EMBOLISM AND THROMBOSIS OF UNSPECIFIED DEEP VESSELS
OF LOWER EXTREMITY |
| 453.41 | VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF PROXIMAL
LOWER EXTREMITY |
| 453.42 | VENOUS EMBOLISM AND THROMBOSIS OF DEEP VESSELS OF DISTAL
LOWER EXTREMITY |
| 456.0 | ESOPHAGEAL VARICES WITH BLEEDING |
| 456.1 | ESOPHAGEAL VARICES WITHOUT BLEEDING |
| 456.20 | ESOPHAGEAL VARICES IN DISEASES CLASSIFIED ELSEWHERE WITH
BLEEDING |
| 456.21 | ESOPHAGEAL VARICES IN DISEASES CLASSIFIED ELSEWHERE WITHOUT
BLEEDING |
| 555.0 | REGIONAL ENTERITIS OF SMALL INTESTINE |
| 555.1 | REGIONAL ENTERITIS OF LARGE INTESTINE |
| 555.2 | REGIONAL ENTERITIS OF SMALL INTESTINE WITH LARGE INTESTINE |
| 555.9 | REGIONAL ENTERITIS OF UNSPECIFIED SITE |
| 556.0 | ULCERATIVE (CHRONIC) ENTEROCOLITIS |
| 556.1 | ULCERATIVE (CHRONIC) ILEOCOLITIS |
| 556.2 | ULCERATIVE (CHRONIC) PROCTITIS |
| 556.3 | ULCERATIVE (CHRONIC) PROCTOSIGMOIDITIS |
| 556.4 | PSEUDOPOLYPOSIS OF COLON |
| 556.5 | LEFT-SIDED ULCERATIVE (CHRONIC) COLITIS |
| 556.6 | UNIVERSAL ULCERATIVE (CHRONIC) COLITIS |
| 556.8 | OTHER ULCERATIVE COLITIS |
| 556.9 | ULCERATIVE COLITIS UNSPECIFIED |
| 557.0 | ACUTE VASCULAR INSUFFICIENCY OF INTESTINE |
| 558.1 | GASTROENTERITIS AND COLITIS DUE TO RADIATION |
| 558.2 | TOXIC GASTROENTERITIS AND COLITIS |
| 558.3 | ALLERGIC GASTROENTERITIS AND COLITIS |
| 558.41 | EOSINOPHILIC GASTROENTERITIS |
| 558.42 | EOSINOPHILIC COLITIS |
| 558.9 | OTHER AND UNSPECIFIED NONINFECTIOUS GASTROENTERITIS AND
COLITIS |
| 558.41 | EOSINOPHILIC GASTROENTERITIS |
| 558.42 | EOSINOPHILIC COLITIS |
| 560.0 | INTUSSUSCEPTION |
| 560.1 | PARALYTIC ILEUS |
| 560.2 | VOLVULUS OF INTESTINE |
| 560.30 | IMPACTION OF INTESTINE UNSPECIFIED |
| 560.31 | GALLSTONE ILEUS |
| 560.39 | OTHER IMPACTION OF INTESTINE |
| 560.81 | INTESTINAL OR PERITONEAL ADHESIONS WITH OBSTRUCTION
(POSTOPERATIVE) (POSTINFECTION) |
| 560.89 | OTHER SPECIFIED INTESTINAL OBSTRUCTION |
| 560.9 | UNSPECIFIED INTESTINAL OBSTRUCTION |
| 562.01 | DIVERTICULITIS OF SMALL INTESTINE (WITHOUT HEMORRHAGE) |
| 562.03 | DIVERTICULITIS OF SMALL INTESTINE WITH HEMORRHAGE |
| 562.11 | DIVERTICULITIS OF COLON (WITHOUT HEMORRHAGE) |
| 562.13 | DIVERTICULITIS OF COLON WITH HEMORRHAGE |
| 567.0 | PERITONITIS IN INFECTIOUS DISEASES CLASSIFIED ELSEWHERE |
| 567.1 | PNEUMOCOCCAL PERITONITIS |
| 567.21 | PERITONITIS (ACUTE) GENERALIZED |
| 567.22 | PERITONEAL ABSCESS |
| 567.23 | SPONTANEOUS BACTERIAL PERITONITIS |
| 567.29 | OTHER SUPPURATIVE PERITONITIS |
| 567.38 | OTHER RETROPERITONEAL ABSCESS |
| 567.39 | OTHER RETROPERITONEAL INFECTIONS |
| 567.81 | CHOLEPERITONITIS |
| 567.82 | SCLEROSING MESENTERITIS |
| 567.89 | OTHER SPECIFIED PERITONITIS |
| 567.9 | UNSPECIFIED PERITONITIS |
| 569.83 | PERFORATION OF INTESTINE |
| 570 | ACUTE AND SUBACUTE NECROSIS OF LIVER |
| 571.0 | ALCOHOLIC FATTY LIVER |
| 571.1 | ACUTE ALCOHOLIC HEPATITIS |
| 571.2 | ALCOHOLIC CIRRHOSIS OF LIVER |
| 571.3 | ALCOHOLIC LIVER DAMAGE UNSPECIFIED |
| 571.40 | CHRONIC HEPATITIS UNSPECIFIED |
| 571.41 | CHRONIC PERSISTENT HEPATITIS |
| 571.42 | AUTOIMMUNE HEPATITIS |
| 571.49 | OTHER CHRONIC HEPATITIS |
| 571.5 | CIRRHOSIS OF LIVER WITHOUT ALCOHOL |
| 571.6 | BILIARY CIRRHOSIS |
| 571.8 | OTHER CHRONIC NONALCOHOLIC LIVER DISEASE |
| 571.9 | UNSPECIFIED CHRONIC LIVER DISEASE WITHOUT ALCOHOL |
| 571.42 | AUTOIMMUNE HEPATITIS |
| 572.0 | ABSCESS OF LIVER |
| 572.1 | PORTAL PYEMIA |
| 572.2 | HEPATIC COMA |
| 572.3 | PORTAL HYPERTENSION |
| 572.4 | HEPATORENAL SYNDROME |
| 572.8 | OTHER SEQUELAE OF CHRONIC LIVER DISEASE |
| 573.0 | CHRONIC PASSIVE CONGESTION OF LIVER |
| 573.1 | HEPATITIS IN VIRAL DISEASES CLASSIFIED ELSEWHERE |
| 573.2 | HEPATITIS IN OTHER INFECTIOUS DISEASES CLASSIFIED ELSEWHERE |
| 573.3 | HEPATITIS UNSPECIFIED |
| 573.4 | HEPATIC INFARCTION |
| 573.8 | OTHER SPECIFIED DISORDERS OF LIVER |
| 573.9 | UNSPECIFIED DISORDER OF LIVER |
| 574.00 | CALCULUS OF GALLBLADDER WITH ACUTE CHOLECYSTITIS WITHOUT
OBSTRUCTION |
| 574.01 | CALCULUS OF GALLBLADDER WITH ACUTE CHOLECYSTITIS WITH
OBSTRUCTION |
| 574.10 | CALCULUS OF GALLBLADDER WITH OTHER CHOLECYSTITIS WITHOUT
OBSTRUCTION |
| 574.11 | CALCULUS OF GALLBLADDER WITH OTHER CHOLECYSTITIS WITH
OBSTRUCTION |
| 574.20 | CALCULUS OF GALLBLADDER WITHOUT CHOLECYSTITIS WITHOUT
OBSTRUCTION |
| 574.21 | CALCULUS OF GALLBLADDER WITHOUT CHOLECYSTITIS WITH
OBSTRUCTION |
| 574.30 | CALCULUS OF BILE DUCT WITH ACUTE CHOLECYSTITIS WITHOUT
OBSTRUCTION |
| 574.31 | CALCULUS OF BILE DUCT WITH ACUTE CHOLECYSTITIS WITH
OBSTRUCTION |
| 574.40 | CALCULUS OF BILE DUCT WITH OTHER CHOLECYSTITIS WITHOUT
OBSTRUCTION |
| 574.41 | CALCULUS OF BILE DUCT WITH OTHER CHOLECYSTITIS WITH
OBSTRUCTION |
| 574.50 | CALCULUS OF BILE DUCT WITHOUT CHOLECYSTITIS WITHOUT
OBSTRUCTION |
| 574.51 | CALCULUS OF BILE DUCT WITHOUT CHOLECYSTITIS WITH
OBSTRUCTION |
| 574.60 | CALCULUS OF GALLBLADDER AND BILE DUCT WITH ACUTE
CHOLECYSTITIS WITHOUT OBSTRUCTION |
| 574.61 | CALCULUS OF GALLBLADDER AND BILE DUCT WITH ACUTE
CHOLECYSTITIS WITH OBSTRUCTION |
| 574.70 | CALCULUS OF GALLBLADDER AND BILE DUCT WITH OTHER
CHOLECYSTITIS WITHOUT OBSTRUCTION |
| 574.71 | CALCULUS OF GALLBLADDER AND BILE DUCT WITH OTHER
CHOLECYSTITIS WITH OBSTRUCTION |
| 574.80 | CALCULUS OF GALLBLADDER AND BILE DUCT WITH ACUTE AND
CHRONIC CHOLECYSTITIS WITHOUT OBSTRUCTION |
| 574.81 | CALCULUS OF GALLBLADDER AND BILE DUCT WITH ACUTE AND
CHRONIC CHOLECYSTITIS WITH OBSTRUCTION |
| 574.90 | CALCULUS OF GALLBLADDER AND BILE DUCT WITHOUT CHOLECYSTITIS
WITHOUT OBSTRUCTION |
| 574.91 | CALCULUS OF GALLBLADDER AND BILE DUCT WITHOUT CHOLECYSTITIS
WITH OBSTRUCTION |
| 575.0 | ACUTE CHOLECYSTITIS |
| 575.10 | CHOLECYSTITIS UNSPECIFIED |
| 575.11 | CHRONIC CHOLECYSTITIS |
| 575.12 | ACUTE AND CHRONIC CHOLECYSTITIS |
| 575.2 | OBSTRUCTION OF GALLBLADDER |
| 575.3 | HYDROPS OF GALLBLADDER |
| 575.4 | PERFORATION OF GALLBLADDER |
| 575.5 | FISTULA OF GALLBLADDER |
| 575.6 | CHOLESTEROLOSIS OF GALLBLADDER |
| 575.8 | OTHER SPECIFIED DISORDERS OF GALLBLADDER |
| 575.9 | UNSPECIFIED DISORDER OF GALLBLADDER |
| 576.0 | POSTCHOLECYSTECTOMY SYNDROME |
| 576.1 | CHOLANGITIS |
| 576.2 | OBSTRUCTION OF BILE DUCT |
| 576.3 | PERFORATION OF BILE DUCT |
| 576.4 | FISTULA OF BILE DUCT |
| 576.5 | SPASM OF SPHINCTER OF ODDI |
| 576.8 | OTHER SPECIFIED DISORDERS OF BILIARY TRACT |
| 576.9 | UNSPECIFIED DISORDER OF BILIARY TRACT |
| 581.0 | NEPHROTIC SYNDROME WITH LESION OF PROLIFERATIVE
GLOMERULONEPHRITIS |
| 581.1 | NEPHROTIC SYNDROME WITH LESION OF MEMBRANOUS
GLOMERULONEPHRITIS |
| 581.2 | NEPHROTIC SYNDROME WITH LESION OF MEMBRANOPROLIFERATIVE
GLOMERULONEPHRITIS |
| 581.3 | NEPHROTIC SYNDROME WITH LESION OF MINIMAL CHANGE
GLOMERULONEPHRITIS |
| 581.81 | NEPHROTIC SYNDROME IN DISEASES CLASSIFIED ELSEWHERE |
| 581.89 | OTHER NEPHROTIC SYNDROME WITH SPECIFIED PATHOLOGICAL LESION
IN KIDNEY |
| 581.9 | NEPHROTIC SYNDROME WITH UNSPECIFIED PATHOLOGICAL LESION IN
KIDNEY |
| 582.0 | CHRONIC GLOMERULONEPHRITIS WITH LESION OF PROLIFERATIVE
GLOMERULONEPHRITIS |
| 582.1 | CHRONIC GLOMERULONEPHRITIS WITH LESION OF MEMBRANOUS
GLOMERULONEPHRITIS |
| 582.2 | CHRONIC GLOMERULONEPHRITIS WITH LESION OF
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS |
| 582.4 | CHRONIC GLOMERULONEPHRITIS WITH LESION OF RAPIDLY
PROGRESSIVE GLOMERULONEPHRITIS |
| 582.81 | CHRONIC GLOMERULONEPHRITIS IN DISEASES CLASSIFIED ELSEWHERE |
| 582.89 | OTHER CHRONIC GLOMERULONEPHRITIS WITH SPECIFIED
PATHOLOGICAL LESION IN KIDNEY |
| 582.9 | CHRONIC GLOMERULONEPHRITIS WITH UNSPECIFIED PATHOLOGICAL
LESION IN KIDNEY |
| 583.0 | NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC
WITH LESION OF PROLIFERATIVE GLOMERULONEPHRITIS |
| 583.1 | NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC
WITH LESION OF MEMBRANOUS GLOMERULONEPHRITIS |
| 583.2 | NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC
WITH LESION OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS |
| 583.4 | NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC
WITH LESION OF RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS |
| 583.6 | NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC
WITH LESION OF RENAL CORTICAL NECROSIS |
| 583.7 | NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC
WITH LESION OF RENAL MEDULLARY NECROSIS |
| 583.81 | NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC
IN DISEASES CLASSIFIED ELSEWHERE |
| 583.89 | OTHER NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR
CHRONIC WITH SPECIFIED PATHOLOGICAL LESION IN KIDNEY |
| 583.9 | NEPHRITIS AND NEPHROPATHY NOT SPECIFIED AS ACUTE OR CHRONIC
WITH UNSPECIFIED PATHOLOGICAL LESION IN KIDNEY |
| 584.5 | ACUTE RENAL FAILURE WITH LESION OF TUBULAR NECROSIS |
| 584.6 | ACUTE RENAL FAILURE WITH LESION OF RENAL CORTICAL NECROSIS |
| 584.7 | ACUTE RENAL FAILURE WITH LESION OF RENAL MEDULLARY
(PAPILLARY) NECROSIS |
| 584.8 | ACUTE RENAL FAILURE WITH OTHER SPECIFIED PATHOLOGICAL
LESION IN KIDNEY |
| 584.9 | ACUTE RENAL FAILURE UNSPECIFIED |
| 585.6 | END STAGE RENAL DISEASE |
| 586 | RENAL FAILURE UNSPECIFIED |
| 587 | RENAL SCLEROSIS UNSPECIFIED |
| 588.0 | RENAL OSTEODYSTROPHY |
| 588.1 | NEPHROGENIC DIABETES INSIPIDUS |
| 588.81 | SECONDARY HYPERPARATHYROIDISM (OF RENAL ORIGIN) |
| 588.89 | OTHER SPECIFIED DISORDERS RESULTING FROM IMPAIRED RENAL
FUNCTION |
| 588.9 | UNSPECIFIED DISORDER RESULTING FROM IMPAIRED RENAL FUNCTION |
| 590.00 | CHRONIC PYELONEPHRITIS WITHOUT LESION OF RENAL MEDULLARY
NECROSIS |
| 590.01 | CHRONIC PYELONEPHRITIS WITH LESION OF RENAL MEDULLARY
NECROSIS |
| 590.10 | ACUTE PYELONEPHRITIS WITHOUT LESION OF RENAL MEDULLARY
NECROSIS |
| 590.11 | ACUTE PYELONEPHRITIS WITH LESION OF RENAL MEDULLARY
NECROSIS |
| 590.2 | RENAL AND PERINEPHRIC ABSCESS |
| 590.3 | PYELOURETERITIS CYSTICA |
| 590.80 | PYELONEPHRITIS UNSPECIFIED |
| 590.81 | PYELITIS OR PYELONEPHRITIS IN DISEASES CLASSIFIED ELSEWHERE |
| 590.9 | INFECTION OF KIDNEY UNSPECIFIED |
| 642.50 | SEVERE PRE-ECLAMPSIA UNSPECIFIED AS TO EPISODE OF CARE |
| 642.51 | SEVERE PRE-ECLAMPSIA WITH DELIVERY |
| 642.52 | SEVERE PRE-ECLAMPSIA WITH DELIVERY WITH POSTPARTUM
COMPLICATION |
| 642.53 | SEVERE PRE-ECLAMPSIA ANTEPARTUM |
| 642.54 | SEVERE PRE-ECLAMPSIA POSTPARTUM |
| 646.70 | LIVER DISORDERS IN PREGNANCY UNSPECIFIED AS TO EPISODE OF
CARE |
| 646.71 | LIVER DISORDERS IN PREGNANCY WITH DELIVERY |
| 646.73 | ANTEPARTUM LIVER DISORDERS |
| 782.4 | JAUNDICE UNSPECIFIED NOT OF NEWBORN |
| 789.1 | HEPATOMEGALY |
| 790.4 | NONSPECIFIC ELEVATION OF LEVELS OF TRANSAMINASE OR LACTIC
ACID DEHYDROGENASE (LDH) |
| 790.5 | OTHER NONSPECIFIC ABNORMAL SERUM ENZYME LEVELS |
| 960.0 | POISONING BY PENICILLINS |
| 960.1 | POISONING BY ANTIFUNGAL ANTIBIOTICS |
| 960.2 | POISONING BY CHLORAMPHENICOL GROUP |
| 960.3 | POISONING BY ERYTHROMYCIN AND OTHER MACROLIDES |
| 960.4 | POISONING BY TETRACYCLINE GROUP |
| 960.5 | POISONING OF CEPHALOSPORIN GROUP |
| 960.6 | POISONING OF ANTIMYCOBACTERIAL ANTIBIOTICS |
| 960.7 | POISONING BY ANTINEOPLASTIC ANTIBIOTICS |
| 960.8 | POISONING BY OTHER SPECIFIED ANTIBIOTICS |
| 960.9 | POISONING BY UNSPECIFIED ANTIBIOTIC |
| 961.0 | POISONING BY SULFONAMIDES |
| 961.1 | POISONING BY ARSENICAL ANTI-INFECTIVES |
| 961.2 | POISONING BY HEAVY METAL ANTI-INFECTIVES |
| 961.3 | POISONING BY QUINOLINE AND HYDROXYQUINOLINE DERIVATIVES |
| 961.4 | POISONING BY ANTIMALARIALS AND DRUGS ACTING ON OTHER BLOOD
PROTOZOA |
| 961.5 | POISONING BY OTHER ANTIPROTOZOAL DRUGS |
| 961.6 | POISONING BY ANTHELMINTICS |
| 961.7 | POISONING BY ANTIVIRAL DRUGS |
| 961.8 | POISONING BY OTHER ANTIMYCOBACTERIAL DRUGS |
| 961.9 | POISONING BY OTHER AND UNSPECIFIED ANTI-INFECTIVES |
| 962.0 | POISONING BY ADRENAL CORTICAL STEROIDS |
| 962.1 | POISONING BY ANDROGENS AND ANABOLIC CONGENERS |
| 962.2 | POISONING BY OVARIAN HORMONES AND SYNTHETIC SUBSTITUTES |
| 962.3 | POISONING BY INSULINS AND ANTIDIABETIC AGENTS |
| 962.4 | POISONING BY ANTERIOR PITUITARY HORMONES |
| 962.5 | POISONING BY POSTERIOR PITUITARY HORMONES |
| 962.6 | POISONING BY PARATHYROID AND PARATHYROID DERIVATIVES |
| 962.7 | POISONING BY THYROID AND THYROID DERIVATIVES |
| 962.8 | POISONING BY ANTITHYROID AGENTS |
| 962.9 | POISONING BY OTHER AND UNSPECIFIED HORMONES AND SYNTHETIC
SUBSTITUTES |
| 963.0 | POISONING BY ANTIALLERGIC AND ANTIEMETIC DRUGS |
| 963.1 | POISONING BY ANTINEOPLASTIC AND IMMUNOSUPPRESSIVE DRUGS |
| 963.2 | POISONING BY ACIDIFYING AGENTS |
| 963.3 | POISONING BY ALKALIZING AGENTS |
| 963.4 | POISONING BY ENZYMES NOT ELSEWHERE CLASSIFIED |
| 963.5 | POISONING BY VITAMINS NOT ELSEWHERE CLASSIFIED |
| 963.8 | POISONING BY OTHER SPECIFIED SYSTEMIC AGENTS |
| 963.9 | POISONING BY UNSPECIFIED SYSTEMIC AGENT |
| 964.0 | POISONING BY IRON AND ITS COMPOUNDS |
| 964.1 | POISONING BY LIVER PREPARATIONS AND OTHER ANTIANEMIC AGENTS |
| 964.2 | POISONING BY ANTICOAGULANTS |
| 964.3 | POISONING BY VITAMIN K (PHYTONADIONE) |
| 964.4 | POISONING BY FIBRINOLYSIS-AFFECTING DRUGS |
| 964.5 | POISONING BY ANTICOAGULANT ANTAGONISTS AND OTHER COAGULANTS |
| 964.6 | POISONING BY GAMMA GLOBULIN |
| 964.7 | POISONING BY NATURAL BLOOD AND BLOOD PRODUCTS |
| 964.8 | POISONING BY OTHER SPECIFIED AGENTS AFFECTING BLOOD
CONSTITUENTS |
| 964.9 | POISONING BY UNSPECIFIED AGENT AFFECTING BLOOD CONSTITUENTS |
| 965.00 | POISONING BY OPIUM (ALKALOIDS) UNSPECIFIED |
| 965.01 | POISONING BY HEROIN |
| 965.02 | POISONING BY METHADONE |
| 965.09 | POISONING BY OTHER OPIATES AND RELATED NARCOTICS |
| 965.1 | POISONING BY SALICYLATES |
| 965.4 | POISONING BY AROMATIC ANALGESICS NOT ELSEWHERE CLASSIFIED |
| 965.5 | POISONING BY PYRAZOLE DERIVATIVES |
| 965.61 | POISONING BY PROPIONIC ACID DERIVATIVES |
| 965.69 | POISONING BY OTHER ANTIRHEUMATICS |
| 965.7 | POISONING BY OTHER NON-NARCOTIC ANALGESICS |
| 965.8 | POISONING BY OTHER SPECIFIED ANALGESICS AND ANTIPYRETICS |
| 965.9 | POISONING BY UNSPECIFIED ANALGESIC AND ANTIPYRETIC |
| 966.0 | POISONING BY OXAZOLIDINE DERIVATIVES |
| 966.1 | POISONING BY HYDANTOIN DERIVATIVES |
| 966.2 | POISONING BY SUCCINIMIDES |
| 966.3 | POISONING BY OTHER AND UNSPECIFIED ANTICONVULSANTS |
| 966.4 | POISONING BY ANTI-PARKINSONISM DRUGS |
| 967.0 | POISONING BY BARBITURATES |
| 967.1 | POISONING BY CHLORAL HYDRATE GROUP |
| 967.2 | POISONING BY PARALDEHYDE |
| 967.3 | POISONING BY BROMINE COMPOUNDS |
| 967.4 | POISONING BY METHAQUALONE COMPOUNDS |
| 967.5 | POISONING BY GLUTETHIMIDE GROUP |
| 967.6 | POISONING BY MIXED SEDATIVES NOT ELSEWHERE CLASSIFIED |
| 967.8 | POISONING BY OTHER SEDATIVES AND HYPNOTICS |
| 967.9 | POISONING BY UNSPECIFIED SEDATIVE OR HYPNOTIC |
| 968.0 | POISONING BY CENTRAL NERVOUS SYSTEM MUSCLE-TONE DEPRESSANTS |
| 968.1 | POISONING BY HALOTHANE |
| 968.2 | POISONING BY OTHER GASEOUS ANESTHETICS |
| 968.3 | POISONING BY INTRAVENOUS ANESTHETICS |
| 968.4 | POISONING BY OTHER AND UNSPECIFIED GENERAL ANESTHETICS |
| 968.5 | POISONING BY SURFACE (TOPICAL) AND INFILTRATION ANESTHETICS |
| 968.6 | POISONING BY PERIPHERAL NERVE- AND PLEXUS-BLOCKING
ANESTHETICS |
| 968.7 | POISONING BY SPINAL ANESTHETICS |
| 968.9 | POISONING BY OTHER AND UNSPECIFIED LOCAL ANESTHETICS |
| 969.0 | POISONING BY ANTIDEPRESSANTS |
| 969.1 | POISONING BY PHENOTHIAZINE-BASED TRANQUILIZERS |
| 969.2 | POISONING BY BUTYROPHENONE-BASED TRANQUILIZERS |
| 969.3 | POISONING BY OTHER ANTIPSYCHOTICS NEUROLEPTICS AND MAJOR
TRANQUILIZERS |
| 969.4 | POISONING BY BENZODIAZEPINE-BASED TRANQUILIZERS |
| 969.5 | POISONING BY OTHER TRANQUILIZERS |
| 969.6 | POISONING BY PSYCHODYSLEPTICS (HALLUCINOGENS) |
| 969.7 | POISONING BY PSYCHOSTIMULANTS |
| 969.8 | POISONING BY OTHER SPECIFIED PSYCHOTROPIC AGENTS |
| 969.9 | POISONING BY UNSPECIFIED PSYCHOTROPIC AGENT |
| 970.0 | POISONING BY ANALEPTICS |
| 970.1 | POISONING BY OPIATE ANTAGONISTS |
| 970.8 | POISONING BY OTHER SPECIFIED CENTRAL NERVOUS SYSTEM
STIMULANTS |
| 970.9 | POISONING BY UNSPECIFIED CENTRAL NERVOUS SYSTEM STIMULANT |
| 971.0 | POISONING BY PARASYMPATHOMIMETICS (CHOLINERGICS) |
| 971.1 | POISONING BY PARASYMPATHOLYTICS (ANTICHOLINERGICS AND
ANTIMUSCARINICS) AND SPASMOLYTICS |
| 971.2 | POISONING BY SYMPATHOMIMETICS (ADRENERGICS) |
| 971.3 | POISONING BY SYMPATHOLYTICS (ANTIADRENERGICS) |
| 971.9 | POISONING BY UNSPECIFIED DRUG PRIMARILY AFFECTING AUTONOMIC
NERVOUS SYSTEM |
| 972.0 | POISONING BY CARDIAC RHYTHM REGULATORS |
| 972.1 | POISONING BY CARDIOTONIC GLYCOSIDES AND DRUGS OF SIMILAR
ACTION |
| 972.2 | POISONING BY ANTILIPEMIC AND ANTIARTERIOSCLEROTIC DRUGS |
| 972.3 | POISONING BY GANGLION-BLOCKING AGENTS |
| 972.4 | POISONING BY CORONARY VASODILATORS |
| 972.5 | POISONING BY OTHER VASODILATORS |
| 972.6 | POISONING BY OTHER ANTIHYPERTENSIVE AGENTS |
| 972.7 | POISONING BY ANTIVARICOSE DRUGS INCLUDING SCLEROSING AGENTS |
| 972.8 | POISONING BY CAPILLARY-ACTIVE DRUGS |
| 972.9 | POISONING BY OTHER AND UNSPECIFIED AGENTS PRIMARILY
AFFECTING THE CARDIOVASCULAR SYSTEM |
| 973.0 | POISONING BY ANTACIDS AND ANTIGASTRIC SECRETION DRUGS |
| 973.1 | POISONING BY IRRITANT CATHARTICS |
| 973.2 | POISONING BY EMOLLIENT CATHARTICS |
| 973.3 | POISONING BY OTHER CATHARTICS INCLUDING INTESTINAL ATONIA |
| 973.4 | POISONING BY DIGESTANTS |
| 973.5 | POISONING BY ANTIDIARRHEAL DRUGS |
| 973.6 | POISONING BY EMETICS |
| 973.8 | POISONING BY OTHER SPECIFIED AGENTS PRIMARILY AFFECTING THE
GASTROINTESTINAL SYSTEM |
| 973.9 | POISONING BY UNSPECIFIED AGENT PRIMARILY AFFECTING THE
GASTROINTESTINAL SYSTEM |
| 974.0 | POISONING BY MERCURIAL DIURETICS |
| 974.1 | POISONING BY PURINE DERIVATIVE DIURETICS |
| 974.2 | POISONING BY CARBONIC ACID ANHYDRASE INHIBITORS |
| 974.3 | POISONING BY SALURETICS |
| 974.4 | POISONING BY OTHER DIURETICS |
| 974.5 | POISONING BY ELECTROLYTIC CALORIC AND WATER-BALANCE AGENTS |
| 974.6 | POISONING BY OTHER MINERAL SALTS NOT ELSEWHERE CLASSIFIED |
| 974.7 | POISONING BY URIC ACID METABOLISM DRUGS |
| 975.0 | POISONING BY OXYTOCIC AGENTS |
| 975.1 | POISONING BY SMOOTH MUSCLE RELAXANTS |
| 975.2 | POISONING BY SKELETAL MUSCLE RELAXANTS |
| 975.3 | POISONING BY OTHER AND UNSPECIFIED DRUGS ACTING ON MUSCLES |
| 975.4 | POISONING BY ANTITUSSIVES |
| 975.5 | POISONING BY EXPECTORANTS |
| 975.6 | POISONING BY ANTI-COMMON COLD DRUGS |
| 975.7 | POISONING BY ANTIASTHMATICS |
| 975.8 | POISONING BY OTHER AND UNSPECIFIED RESPIRATORY DRUGS |
| 976.0 | POISONING BY LOCAL ANTI-INFECTIVES AND ANTI-INFLAMMATORY
DRUGS |
| 976.1 | POISONING BY ANTIPRURITICS |
| 976.2 | POISONING BY LOCAL ASTRINGENTS AND LOCAL DETERGENTS |
| 976.3 | POISONING BY EMOLLIENTS DEMULCENTS AND PROTECTANTS |
| 976.4 | POISONING BY KERATOLYTICS KERATOPLASTICS OTHER HAIR
TREATMENT DRUGS AND PREPARATIONS |
| 976.5 | POISONING BY EYE ANTI-INFECTIVES AND OTHER EYE DRUGS |
| 976.6 | POISONING BY ANTI-INFECTIVES AND OTHER DRUGS AND
PREPARATIONS FOR EAR NOSE AND THROAT |
| 976.7 | POISONING BY DENTAL DRUGS TOPICALLY APPLIED |
| 976.8 | POISONING BY OTHER AGENTS PRIMARILY AFFECTING SKIN AND
MUCOUS MEMBRANE |
| 976.9 | POISONING BY UNSPECIFIED AGENT PRIMARILY AFFECTING SKIN AND
MUCOUS MEMBRANE |
| 977.0 | POISONING BY DIETETICS |
| 977.1 | POISONING BY LIPOTROPIC DRUGS |
| 977.2 | POISONING BY ANTIDOTES AND CHELATING AGENTS NOT ELSEWHERE
CLASSIFIED |
| 977.3 | POISONING BY ALCOHOL DETERRENTS |
| 977.4 | POISONING BY PHARMACEUTICAL EXCIPIENTS |
| 977.8 | POISONING BY OTHER SPECIFIED DRUGS AND MEDICINAL SUBSTANCES |
| 977.9 | POISONING BY UNSPECIFIED DRUG OR MEDICINAL SUBSTANCE |
| 978.0 | POISONING BY BCG VACCINE |
| 978.1 | POISONING BY TYPHOID AND PARATYPHOID VACCINE |
| 978.2 | POISONING BY CHOLERA VACCINE |
| 978.3 | POISONING BY PLAGUE VACCINE |
| 978.4 | POISONING BY TETANUS VACCINE |
| 978.5 | POISONING BY DIPHTHERIA VACCINE |
| 978.6 | POISONING BY PERTUSSIS VACCINE INCLUDING COMBINATIONS WITH
A PERTUSSIS COMPONENT |
| 978.8 | POISONING BY OTHER AND UNSPECIFIED BACTERIAL VACCINES |
| 978.9 | POISONING BY MIXED BACTERIAL VACCINES EXCEPT COMBINATIONS
WITH A PERTUSSIS COMPONENT |
| 979.0 | POISONING BY SMALLPOX VACCINE |
| 979.1 | POISONING BY RABIES VACCINE |
| 979.2 | POISONING BY TYPHUS VACCINE |
| 979.3 | POISONING BY YELLOW FEVER VACCINE |
| 979.4 | POISONING BY MEASLES VACCINE |
| 979.5 | POISONING BY POLIOMYELITIS VACCINE |
| 979.6 | POISONING BY OTHER AND UNSPECIFIED VIRAL AND RICKETTSIAL
VACCINES |
| 979.7 | POISONING BY MIXED VIRAL-RICKETTSIAL AND BACTERIAL VACCINES
EXCEPT COMBINATIONS WITH A PERTUSSIS COMPONENT |
| 979.9 | POISONING BY OTHER AND UNSPECIFIED VACCINES AND BIOLOGICAL
SUBSTANCES |
| 980.0 | TOXIC EFFECT OF ETHYL ALCOHOL |
| 980.1 | TOXIC EFFECT OF METHYL ALCOHOL |
| 980.2 | TOXIC EFFECT OF ISOPROPYL ALCOHOL |
| 980.3 | TOXIC EFFECT OF FUSEL OIL |
| 980.8 | TOXIC EFFECT OF OTHER SPECIFIED ALCOHOLS |
| 980.9 | TOXIC EFFECT OF UNSPECIFIED ALCOHOL |
| 981 | TOXIC EFFECT OF PETROLEUM PRODUCTS |
| 982.0 | TOXIC EFFECT OF BENZENE AND HOMOLOGUES |
| 982.1 | TOXIC EFFECT OF CARBON TETRACHLORIDE |
| 982.2 | TOXIC EFFECT OF CARBON DISULFIDE |
| 982.3 | TOXIC EFFECT OF OTHER CHLORINATED HYDROCARBON SOLVENTS |
| 982.4 | TOXIC EFFECT OF NITROGLYCOL |
| 982.8 | TOXIC EFFECT OF OTHER NONPETROLEUM-BASED SOLVENTS |
| 983.0 | TOXIC EFFECT OF CORROSIVE AROMATICS |
| 983.1 | TOXIC EFFECT OF ACIDS |
| 983.2 | TOXIC EFFECT OF CAUSTIC ALKALIS |
| 983.9 | TOXIC EFFECT OF CAUSTIC UNSPECIFIED |
| 984.0 | TOXIC EFFECT OF INORGANIC LEAD COMPOUNDS |
| 984.1 | TOXIC EFFECT OF ORGANIC LEAD COMPOUNDS |
| 984.8 | TOXIC EFFECT OF OTHER LEAD COMPOUNDS |
| 984.9 | TOXIC EFFECT OF UNSPECIFIED LEAD COMPOUND |
| 985.0 | TOXIC EFFECT OF MERCURY AND ITS COMPOUNDS |
| 985.1 | TOXIC EFFECT OF ARSENIC AND ITS COMPOUNDS |
| 985.2 | TOXIC EFFECT OF MANGANESE AND ITS COMPOUNDS |
| 985.3 | TOXIC EFFECT OF BERYLLIUM AND ITS COMPOUNDS |
| 985.4 | TOXIC EFFECT OF ANTIMONY AND ITS COMPOUNDS |
| 985.5 | TOXIC EFFECT OF CADMIUM AND ITS COMPOUNDS |
| 985.6 | TOXIC EFFECT OF CHROMIUM |
| 985.8 | TOXIC EFFECT OF OTHER SPECIFIED METALS |
| 985.9 | TOXIC EFFECT OF UNSPECIFIED METAL |
| 986 | TOXIC EFFECT OF CARBON MONOXIDE |
| 987.0 | TOXIC EFFECT OF LIQUEFIED PETROLEUM GASES |
| 987.1 | TOXIC EFFECT OF OTHER HYDROCARBON GAS |
| 987.2 | TOXIC EFFECT OF NITROGEN OXIDES |
| 987.3 | TOXIC EFFECT OF SULFUR DIOXIDE |
| 987.4 | TOXIC EFFECT OF FREON |
| 987.5 | TOXIC EFFECT OF LACRIMOGENIC GAS |
| 987.6 | TOXIC EFFECT OF CHLORINE GAS |
| 987.7 | TOXIC EFFECT OF HYDROCYANIC ACID GAS |
| 987.8 | TOXIC EFFECT OF OTHER SPECIFIED GASES FUMES OR VAPORS |
| 987.9 | TOXIC EFFECT OF UNSPECIFIED GAS FUME OR VAPOR |
| 988.0 | TOXIC EFFECT OF FISH AND SHELLFISH EATEN AS FOOD |
| 988.1 | TOXIC EFFECT OF MUSHROOMS EATEN AS FOOD |
| 988.2 | TOXIC EFFECT OF BERRIES AND OTHER PLANTS EATEN AS FOOD |
| 988.8 | TOXIC EFFECT OF OTHER SPECIFIED NOXIOUS SUBSTANCES EATEN AS
FOOD |
| 988.9 | TOXIC EFFECT OF UNSPECIFIED NOXIOUS SUBSTANCE EATEN AS FOOD |
| 989.0 | TOXIC EFFECT OF HYDROCYANIC ACID AND CYANIDES |
| 989.1 | TOXIC EFFECT OF STRYCHNINE AND SALTS |
| 989.2 | TOXIC EFFECT OF CHLORINATED HYDROCARBONS |
| 989.3 | TOXIC EFFECT OF ORGANOPHOSPHATE AND CARBAMATE |
| 989.4 | TOXIC EFFECT OF OTHER PESTICIDES NOT ELSEWHERE CLASSIFIED |
| 989.5 | TOXIC EFFECT OF VENOM |
| 989.6 | TOXIC EFFECT OF SOAPS AND DETERGENTS |
| 989.7 | TOXIC EFFECT OF AFLATOXIN AND OTHER MYCOTOXIN (FOOD
CONTAMINANTS) |
| 989.81 | TOXIC EFFECT OF ASBESTOS |
| 989.82 | TOXIC EFFECT OF LATEX |
| 989.83 | TOXIC EFFECT OF SILICONE |
| 989.84 | TOXIC EFFECT OF TOBACCO |
| 989.89 | TOXIC EFFECT OF OTHER SUBSTANCE CHIEFLY NONMEDICINAL AS TO
SOURCE NOT ELSEWHERE CLASSIFIED |
| V42.7 | LIVER REPLACED BY TRANSPLANT |
| V58.61 | LONG-TERM (CURRENT) USE OF ANTICOAGULANTS |
| V58.62 | LONG-TERM (CURRENT) USE OF ANTIBIOTICS |
| V58.63 | LONG-TERM (CURRENT) USE OF ANTIPLATELETS/ANTITHROMBOTICS |
| V58.64 | LONG-TERM (CURRENT) USE OF NONSTEROIDAL ANTI-INFLAMMATORIES |
| V58.69 | LONG-TERM (CURRENT) USE OF OTHER MEDICATIONS |
| V67.1 | FOLLOW-UP EXAMINATION FOLLOWING RADIOTHERAPY |
| V67.2 | FOLLOW-UP EXAMINATION FOLLOWING CHEMOTHERAPY |
| V67.51 | FOLLOW-UP EXAMINATION FOLLOWING COMPLETED TREATMENT WITH
HIGH-RISK MEDICATION NOT ELSEWHERE CLASSIFIED |
